Crispr multiplex nucleic acid detection method and corresponding product thereof
By blocking the Cas protein trans-cleaving reporter molecule with oligonucleotide or oligonucleotide analogs in the CRISPR multi-nucleic acid detection method, combining the detection of V-type Cas and VI-type Cas proteins, the difficulty of multiple detection in the prior art is solved. and the problem of high cost of RNA probes, efficient and sensitive multi-nucleic acid detection is achieved.
Patent Information
- Application Number
- PCT/CN2024/094215
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-22
- Filing Date
- 2024-05-20
- Publication Date
- 2024-11-28
AI Technical Summary
Among the existing CRISPR multiple nucleic acid detection methods, there are fewer multiple detection systems based on V-type Cas protein, and the RNA probe of VI-type Cas protein is easily degraded by RNA enzymes, which is costly and difficult to compatible with the needs of multiple detection.
Develop multiple detection systems based on V-type Cas proteins, bind oligonucleotide or oligonucleotide analogs to block Cas protein trans cleavage reporter molecules, and design blocked Cas protein trans cleavage reporter molecules to be compatible with the detection of VI-type Cas proteins , realize multiple detection of V-type Cas and VI-type Cas proteins.
Multiple nucleic acid testing in one system is realized, which reduces the cost of reagents, simplifies the detection operation process, and improves detection sensitivity and specificity.
Smart Images

Figure PCTCN2024094215-FTAPPB-I100001 
Figure PCTCN2024094215-FTAPPB-I100002 
Figure PCTCN2024094215-FTAPPB-I100003
Abstract
Description
CRISPR multiplex nucleic acid detection method and corresponding products Technical Field
[0001] The present invention relates to the field of nucleic acid detection, and specifically to a CRISPR multiple nucleic acid detection method and a kit thereof. Background Art
[0002] CRISPR technology was first discovered and applied in the field of gene editing. With the continuous development and advancement of the technology, CRISPR has also been applied to molecular diagnostics, becoming known as the next generation of molecular diagnostics. The main molecular diagnostic methods developed based on CRISPR technology include the SHERLOCK system and the HOLMES system. The SHERLOCK system utilizes type VI Cas proteins for molecular detection, while the HOLMES system utilizes type V Cas proteins. The application of type V and type VI Cas proteins in molecular detection is based on their trans-cleavage activity. The specific detection principle is that when type V or type VI Cas proteins bind to target crRNA, they can specifically cleave the target nucleic acid and simultaneously activate their trans-cleavage activity. This trans-cleavage activity can efficiently and rapidly cleave single-stranded probes. Detection of the target nucleic acid is achieved by monitoring changes in the single-stranded probe signal. The difference between type V and type VI Cas protein detection platforms is that type V Cas proteins bind to DNA targets and trans-cleave single-stranded DNA probes, while type VI Cas proteins bind to RNA targets and cleave single-stranded RNA probes. Depending on the modification of single-stranded probes, CRISPR molecular diagnostic technology can develop detection platforms with different signal detection methods, such as real-time fluorescence detection system platforms and colloidal gold test strip detection platforms, to meet the needs of different nucleic acid detection application scenarios.
[0003] Since type VI Cas proteins bind to RNA targets, a T7 promoter sequence needs to be introduced during the target amplification process to transcribe the amplified DNA product into an RNA template so that the type VI Cas protein can detect the target. At the same time, molecular diagnostic methods using type VI Cas proteins require RNA probes, which are easily degraded by RNases, difficult to preserve, and have higher synthesis costs than DNA probes. Molecular diagnostic methods based on type V Cas proteins do not require in vitro transcription of the target, and the probes used are DNA probes, which are lower in cost. Overall, molecular diagnostic systems developed based on type V Cas proteins have more advantages under certain conditions.
[0004] Multiplexed detection systems are of great practical significance for expanding the application scenarios of molecular diagnostic projects, reducing reagent costs, and simplifying detection procedures. Currently, there are few reports on multiplexed detection systems based on V-type Cas proteins. For example, Chinese invention patent application CN112301101A uses a guide RNA reporter nucleic acid composite probe with a specific structure to achieve multiplexed detection.
[0005] Therefore, the development of a multiplex detection system based on type V Cas proteins is of great significance for expanding CRISPR multiplex detection methods. At the same time, based on the multiplex detection system based on type V Cas proteins, it can also be compatible with the detection system of type VI Cas proteins, and further combined into a multiplex detection system of type V Cas proteins and type VI Cas proteins.
[0006] Summary of the Invention
[0007] The purpose of the present invention is to provide a detection system based on a multiplex detection system of type V Cas protein, which is also compatible with type VI Cas protein protein, and further combined into a multiplex detection system of type V Cas protein and type VI Cas protein protein.
[0008] In a first aspect, the present invention provides the use of oligonucleotides or oligonucleotide analogs for blocking trans-cleavage of reporter molecules by Cas proteins.
[0009] In another preferred embodiment, it is used to block the trans-cleavage of the reporter molecule by the Cas protein to prevent it from being trans-cleaved by the Cas protein.
[0010] In another preferred embodiment, the oligonucleotide or oligonucleotide analog is modified with a quencher group.
[0011] In another preferred embodiment, the length of the oligonucleotide or oligonucleotide analog is 10-100 nt, preferably, 10-50 nt, more preferably, 15-40 nt, and even more preferably, 15-30 nt.
[0012] The second aspect of the present invention provides a closed Cas protein trans-cleavage reporter molecule, comprising:
[0013] Cas protein trans-cleavage reporter molecules, Cas protein trans-cleavage reporter molecules include single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules, and the single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules do not hybridize with the guide sequence of the guide RNA of the Cas protein;
[0014] An oligonucleotide or an oligonucleotide analogue, wherein the oligonucleotide or the oligonucleotide analogue is complementary to the single-stranded nucleic acid molecule or the single-stranded nucleic acid analogue molecule and blocks the single-stranded nucleic acid molecule or the single-stranded nucleic acid analogue molecule.
[0015] In another preferred embodiment, the Cas protein trans-cleavage reporter molecule is a modified Cas protein trans-cleavage reporter molecule.
[0016] In another preferred embodiment, the modification type of the Cas protein trans-cleavage reporter molecule is a modification type that can prevent the trans-cleavage of the Cas protein, preferably, a thio modification or a locked nucleic acid LNA modification type.
[0017] In another preferred embodiment, thiolation modification or locked nucleic acid (LNA) modification is performed on both ends of the Cas protein trans-cleavage reporter molecule.
[0018] In another preferred embodiment, the fluorescent group and the quenching group are modified at the middle position of the trans-cleavage reporter molecule of the Cas protein.
[0019] In another preferred embodiment, the oligonucleotide or oligonucleotide analog is modified with a quencher group.
[0020] In another preferred embodiment, the Cas protein trans-cleaves the reporter molecule and the oligonucleotide or oligonucleotide analog to form a double-stranded molecule.
[0021] In another preferred embodiment, the Cas protein trans-cleaves the reporter molecule and the oligonucleotide or oligonucleotide analog to form a hairpin molecule.
[0022] The third aspect of the present invention provides a use of a hairpin-type or double-stranded nucleic acid or nucleic acid analog molecule, wherein the hairpin-type or double-stranded nucleic acid or nucleic acid analog molecule comprises:
[0023] A single-stranded nucleic acid molecule or a single-stranded nucleic acid analog molecule that does not hybridize with the guide sequence of the guide RNA of the Cas protein;
[0024] an oligonucleotide or an oligonucleotide analogue, wherein the oligonucleotide or oligonucleotide analogue is complementary to the single-stranded nucleic acid molecule or the single-stranded nucleic acid analogue molecule and blocks the single-stranded nucleic acid molecule or the single-stranded nucleic acid analogue molecule;
[0025] The single-stranded nucleic acid molecule or single-stranded nucleic acid analog molecule and the oligonucleotide or oligonucleotide analog form a double-stranded molecule or a hairpin molecule;
[0026] The double-stranded nucleic acid molecule is used as part of a Cas protein trans-cleavage reporter molecule, for use in a method for detecting the trans-cleavage activity of the Cas protein, or for preparing a composition for detecting the trans-cleavage activity of the Cas protein, or for preparing a product combination for detecting the trans-cleavage activity of the Cas protein, or for preparing a reagent for detecting the trans-cleavage activity of the Cas protein, or for preparing a nucleic acid detection kit for detecting the trans-cleavage activity of the Cas protein, or for preparing a system for detecting the trans-cleavage activity of the Cas protein.
[0027] In another preferred embodiment, the Cas protein trans-cleavage reporter molecule is a modified Cas protein trans-cleavage reporter molecule.
[0028] In another preferred embodiment, the modification type of the Cas protein trans-cleavage reporter molecule is a modification type that can prevent the trans-cleavage of the Cas protein, preferably, a thio modification or a locked nucleic acid LNA modification type.
[0029] In another preferred embodiment, thiolation modification or locked nucleic acid (LNA) modification is performed on both ends of the Cas protein trans-cleavage reporter molecule.
[0030] In another preferred embodiment, the fluorescent group and the quenching group are modified at the middle position of the trans-cleavage reporter molecule of the Cas protein.
[0031] In another preferred embodiment, the oligonucleotide or oligonucleotide analog is modified with a quencher group.
[0032] A fourth aspect of the present invention provides a detection system for detecting a target nucleic acid molecule, comprising:
[0033] Nucleic acid detection compositions No. 1 to N, comprising corresponding Cas proteins No. 1 to N, corresponding guide RNAs No. 1 to N, corresponding Cas protein trans-cleavage reporter molecules No. 1 to N, and corresponding oligonucleotides No. 1 to N or oligonucleotide analogs; wherein the Cas protein is a V-type Cas protein; the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-1, the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-1 is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-2, and so on. The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of this number is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. 1 of this number, except when N=1; the guide RNAs No. 1 to N comprise direct repeats (Direct repeats) capable of binding to the corresponding Cas proteins No. 1 to N. Repeat, DR) sequence and a guide sequence capable of targeting the corresponding target sequences 1 to N; the 1st to Nth Cas protein trans-cleavage reporter molecules include the corresponding 1st to Nth single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules, and the 1st to Nth single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules do not hybridize with the guide sequence of the guide RNA in the system; and the 1st to Nth oligonucleotides or oligonucleotide analogs can be complementary to the corresponding 1st to Nth Cas protein trans-cleavage reporter molecules to form 1st to Nth blocked Cas protein trans-cleavage reporter molecules, and the trans-cleavage activity temperature of the 1st to Nth Cas proteins matches the melting temperature of the corresponding 1st to Nth blocked Cas protein trans-cleavage reporter molecules; wherein N is a positive integer ≥1, preferably, N is 1-20, more preferably, N is 1-15, and more preferably, N=1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11;
[0034] and / or
[0035] The nucleic acid detection composition No. 1' to N', wherein the nucleic acid detection composition No. 1' to N' comprises the corresponding Cas protein No. 1' to N', the corresponding guide RNA No. 1' to N', the corresponding Cas protein trans-cleavage reporter molecule No. 1' to N' and the corresponding oligonucleotide No. 1' to N' or oligonucleotide analog; the Cas protein is a type VI Cas protein; the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N' is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-1, and the The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-1 is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-2, and so on. The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of this number is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of the previous number, except when N'=1'; the guide RNA No. 1' to N' includes a direct repeat (Direct repeat) capable of binding to the corresponding Cas protein No. 1' to N' Repeat, DR) sequence and a guide sequence capable of targeting the corresponding 1' to N' target sequence; the 1' to N' Cas protein trans-cutting reporter molecule includes the corresponding 1' to N' single-stranded nucleic acid molecule or single-stranded nucleic acid analog molecule, and the 1' to N' single-stranded nucleic acid molecule or single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system; and the 1' to N' oligonucleotide or oligonucleotide analog can trans-cut with the corresponding 1' to N' Cas protein The reporter molecules are complementary to each other and can form trans-cleavage reporter molecules of the blocked Cas proteins No. 1' to N', and the trans-cleavage activity temperature of the Cas proteins No. 1' to N' matches the melting temperature of the corresponding trans-cleavage reporter molecules of the blocked Cas proteins No. 1' to N'; wherein N' is a positive integer ≥1', preferably, N' is 1'-20', more preferably, N' is 1'-15', and more preferably, N'=1', 2', 3', 4', 5', 6', 7', 8', 9', 10' or 11'.
[0036] In another preferred example, the oligonucleotides No. 1 to N or oligonucleotide analogs are complementary to the corresponding single-stranded nucleic acid molecules No. 1 to N or single-stranded nucleic acid analog molecules of the corresponding Cas protein trans-cleavage reporter molecules No. 1 to N to form closed Cas protein trans-cleavage reporter molecules.
[0037] In another preferred example, the 1' to N' oligonucleotides or oligonucleotide analogs are complementary to the corresponding 1' to N' single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules of the corresponding 1' to N' Cas protein trans-cleavage reporter molecules to form closed Cas protein trans-cleavage reporter molecules.
[0038] In another preferred embodiment, the detection system for detecting target nucleic acid molecules further comprises:
[0039] a) an Mth nucleic acid detection composition, wherein the Mth nucleic acid detection composition comprises:
[0040] The Mth Cas protein, wherein the Mth Cas protein is a V-type Cas protein, preferably a VA-type Cas protein, more preferably Cas12a;
[0041] an Mth guide RNA, wherein the Mth guide RNA comprises a direct repeat (DR) sequence capable of binding to the Mth Cas protein and a guide sequence capable of targeting the Mth target sequence; and
[0042] The Mth Cas protein trans-cleaves the reporter molecule, wherein the Mth Cas protein trans-cleaves the reporter molecule including the Mth single-stranded nucleic acid molecule or the Mth single-stranded nucleic acid analog molecule, and the Mth single-stranded nucleic acid molecule or the Mth single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system;
[0043] and / or
[0044] The M'th Cas protein, wherein the M'th Cas protein is a type VI Cas protein, preferably a type VI-A Cas protein, more preferably Cas13a;
[0045] an M'th guide RNA, wherein the M'th guide RNA comprises a direct repeat (DR) sequence capable of binding to the M'th Cas protein and a guide sequence capable of targeting the M'th target sequence; and
[0046] The M'Cas protein trans-cleaves the reporter molecule, wherein the M'Cas protein trans-cleaves the reporter molecule, comprising the M' single-stranded nucleic acid molecule or the M' single-stranded nucleic acid analog molecule, wherein the M' single-stranded nucleic acid molecule or the M' single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system;
[0047] The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. 1 to No. N is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. M;
[0048] The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection compositions No. 1' to N' is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. M'.
[0049] A fifth aspect of the present invention provides a multiplex detection system for detecting target nucleic acid molecules, comprising:
[0050] a) a first nucleic acid detection composition, comprising:
[0051] The first type V Cas protein;
[0052] A first guide RNA, comprising a direct repeat (DR) sequence capable of binding to a first V-type Cas protein and a guide sequence capable of targeting a first target sequence; and
[0053] The first Cas protein trans-cleaves the reporter molecule, wherein the first Cas protein trans-cleaves the reporter molecule including a first single-stranded nucleic acid molecule or a first single-stranded nucleic acid analog molecule, and the first single-stranded nucleic acid molecule or the first single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system;
[0054] b) a second nucleic acid detection composition, comprising:
[0055] a second V-type Cas protein, wherein the trans-cleavage activity temperature or inactivation temperature of the second V-type Cas protein is higher than the trans-cleavage activity temperature or inactivation temperature of the first V-type Cas protein;
[0056] a second guide RNA comprising a direct repeat (DR) sequence capable of binding to a second V-type Cas protein and a guide sequence capable of targeting a second target sequence; and
[0057] The second Cas protein trans-cleaves the reporter molecule, wherein the second Cas protein trans-cleaves the reporter molecule including a second single-stranded nucleic acid molecule or a second single-stranded nucleic acid analog molecule, and the second single-stranded nucleic acid molecule or the second single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system;
[0058] An oligonucleotide or oligonucleotide analogue, wherein the oligonucleotide or oligonucleotide analogue is complementary to the second single-stranded nucleic acid molecule or second single-stranded nucleic acid analogue molecule of the second Cas protein trans-cleavage reporter molecule to form a second closed Cas protein trans-cleavage reporter molecule;
[0059] The melting temperature of the second blocked Cas protein trans-cleavage reporter molecule formed by the second Cas protein trans-cleavage reporter molecule and the oligonucleotide or oligonucleotide analog matches the trans-cleavage activity temperature of the second V-type Cas protein;
[0060] The first V-type Cas protein is a V-type Cas protein other than the VB-type Cas protein;
[0061] The second V-type Cas protein is a VB-type Cas protein.
[0062] In another preferred embodiment, the trans-cleavage activity temperature of the second V-type Cas protein is 50-80°C, preferably 55-70°C.
[0063] In another preferred example, the trans-cleavage activity temperature of the first V-type Cas protein is 20-50°C, preferably 30-40°C.
[0064] In another preferred embodiment, the multiplex detection system for detecting target nucleic acid molecules further comprises a third nucleic acid detection composition, and the third nucleic acid detection composition comprises:
[0065] Type III VI Cas proteins;
[0066] a third guide RNA comprising a direct repeat (DR) sequence capable of binding to a third type VI Cas protein and a guide sequence capable of targeting a third target sequence; and
[0067] The third Cas protein trans-cuts the reporter molecule, and the third Cas protein trans-cuts the reporter molecule, which includes a third single-stranded nucleic acid molecule or a third single-stranded nucleic acid analog molecule, and the third single-stranded nucleic acid molecule or the third single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system.
[0068] In another preferred embodiment, the multiplex detection system for detecting target nucleic acid molecules further comprises a fourth nucleic acid detection composition, and the fourth nucleic acid detection composition further comprises:
[0069] A fourth type VI Cas protein; the trans-cleavage activity temperature or inactivation temperature of the fourth type VI Cas protein is higher than the trans-cleavage activity temperature or inactivation temperature of the third type VI Cas protein;
[0070] a fourth guide RNA comprising a direct repeat (DR) sequence capable of binding to a fourth type VI Cas protein and a guide sequence capable of targeting a fourth target sequence; and
[0071] a fourth Cas protein trans-cleaving reporter molecule, wherein the fourth Cas protein trans-cleaving reporter molecule comprises a fourth single-stranded nucleic acid molecule or a fourth single-stranded nucleic acid analog molecule, and the fourth single-stranded nucleic acid molecule or the fourth single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system;
[0072] A fourth oligonucleotide or oligonucleotide analogue, wherein the fourth oligonucleotide or oligonucleotide analogue can be complementary to the fourth single-stranded nucleic acid molecule or the fourth single-stranded nucleic acid analogue molecule of the fourth Cas protein trans-cleavage reporter molecule to form a fourth closed Cas protein trans-cleavage reporter molecule; the trans-cleavage activity temperature or inactivation temperature of the fourth type VI Cas protein is higher than the trans-cleavage activity temperature or inactivation temperature of the third type VI Cas protein; the melting temperature of the fourth closed Cas protein trans-cleavage reporter molecule formed by the fourth Cas protein trans-cleavage reporter molecule and the fourth oligonucleotide or oligonucleotide analogue matches the trans-cleavage activity temperature of the fourth type VI Cas protein, preferably, the fourth type VI Cas protein is a heat-resistant type VI Cas protein, and the third type VI Cas protein is a type VI Cas protein other than the heat-resistant type VI Cas protein.
[0073] In another preferred embodiment, the trans-cleavage activity temperature of the fourth type VI Cas protein is 37-70°C, preferably 50-70°C.
[0074] In another preferred embodiment, the trans-cleavage activity temperature of the third type VI Cas protein is 20-50°C, preferably 30-40°C.
[0075] In another preferred embodiment, the heat-resistant type VI Cas protein includes TccCas13a (from article PMID: 35763567 PMCID: PMC9282225 DOI: 10.1073 / pnas.2118260119).
[0076] In another preferred embodiment, the Cas protein trans-cleaves the reporter molecule and the oligonucleotide or oligonucleotide analog to form a double-stranded molecule.
[0077] In another preferred embodiment, the Cas protein trans-cleaves the reporter molecule and the oligonucleotide or oligonucleotide analog to form a hairpin molecule.
[0078] In another preferred embodiment, the first target sequence is derived from an internal reference gene, selected from the group consisting of an RP internal reference gene, a GAPDH internal reference gene, a β-actin internal reference gene, or a combination thereof.
[0079] In another preferred example, the first target sequence, the second target sequence, the third target sequence, and the fourth target sequence each independently comprise a DNA or RNA target derived from a plant, an animal, an insect, a microorganism, a virus, or a combination thereof.
[0080] In another preferred example, the first target sequence, the second target sequence, the third target sequence, and the fourth target sequence are each independently derived from a nucleic acid molecule selected from the following group: a nucleic acid molecule of a pathogenic microorganism, a nucleic acid molecule of a gene mutation, a specific target nucleic acid molecule, or a combination thereof.
[0081] In another preferred example, the first target sequence, the second target sequence, the third target sequence, and the fourth target sequence are each independently derived from a target gene selected from the group consisting of viruses, bacteria, chlamydia, mycoplasma, or a combination thereof.
[0082] In another preferred embodiment, the virus is selected from the following group: plant virus, animal virus, or a combination thereof.
[0083] In another preferred embodiment, the virus is selected from the following group: coronavirus, influenza virus, HIV, hepatitis virus, parainfluenza virus.
[0084] In another preferred embodiment, the virus is a coronavirus.
[0085] In another preferred embodiment, the virus is selected from the group consisting of SARS, SARS-CoV2 (COVID-19), HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1, MERS-Cov, or a combination thereof.
[0086] In another preferred example, the second target sequence, the third target sequence, and the fourth target sequence may be the same or different.
[0087] In another preferred example, the second target sequence, the third target sequence, and the fourth target sequence are each independently derived from a target gene selected from the following group: the N gene of coronavirus, the ORF1ab of coronavirus, the E gene of coronavirus, the S gene of coronavirus, or a combination thereof.
[0088] In another preferred example, the second target sequence is derived from a DNA target.
[0089] In another preferred embodiment, the third and fourth target sequences are derived from RNA targets.
[0090] In another preferred embodiment, the DNA target includes DNA formed based on RNA reverse transcription.
[0091] In another preferred embodiment, the DNA target includes cDNA.
[0092] In another preferred embodiment, the DNA target is selected from the following group: single-stranded DNA, double-stranded DNA, or a combination thereof.
[0093] In another preferred embodiment, the RNA target includes RNA formed based on DNA transcription.
[0094] In another preferred embodiment, the first, second, third or fourth Cas protein trans-cleavage reporter molecules are each independently selected from the following group: single-stranded nucleic acid molecules, single-stranded nucleic acid analog molecules or a combination thereof.
[0095] In another preferred embodiment, the first, second, third or fourth single-stranded nucleic acid molecule is independently selected from the following group: an unmodified single-stranded nucleic acid molecule, a modified single-stranded nucleic acid molecule, a single-stranded nucleic acid molecule containing an abasic spacer, or a combination thereof.
[0096] In another preferred embodiment, the first, second, third or fourth Cas protein trans-cleavage reporter molecules are each independently selected from the following groups: gold nanoparticle-based reporter molecules, fluorophore-based reporter molecules, fluorescence polarization-based reporter molecules, colloidal phase change / dispersion-based reporter molecules, electrochemical signal-based reporter molecules, semiconductor signal-based reporter molecules, and color-based reporter molecules.
[0097] In another preferred example, the second and fourth Cas protein trans-cleavage reporter molecules are modified Cas protein trans-cleavage reporter molecules.
[0098] In another preferred example, the modification type of the second and fourth Cas protein trans-cleavage reporter molecules is a modification type that can prevent Cas protein trans-cleavage, preferably, a thio modification or a locked nucleic acid LNA modification type.
[0099] In another preferred embodiment, thiolation modification or locked nucleic acid LNA modification is performed at both ends of the second and fourth Cas protein trans-cleavage reporter molecules.
[0100] In another preferred embodiment, the first, second, third, or fourth Cas protein trans-cleavage reporter molecules are each independently a nucleic acid probe.
[0101] In another preferred embodiment, the nucleic acid probe carries a detectable label.
[0102] In another preferred embodiment, the complementary oligonucleotides (oligo) or oligonucleotide analogs of the second and fourth Cas proteins that trans-cleave the reporter molecules are detectably labeled.
[0103] In another preferred embodiment, the detectable label includes a fluorescent group and a quencher group.
[0104] In another preferred embodiment, the fluorescent group is selected from the following group: FAM, HEX, Cy3, Cy5, Cy5.5, Cy7, ROX, VIC, JOE, TET, Texas Red, FITC, LC RED640, RB200, NED, Atto 425, Quasar 670, or a combination thereof.
[0105] In another preferred embodiment, the quenching group is selected from the following group: TAMARA, BHQ1, BHQ2, BHQ3, DABSYL, Dabcyl, eclipse, MGB, or a combination thereof.
[0106] In another preferred embodiment, the fluorescent group and the quencher group are independently located at the 5' end, 3' end and the middle of the nucleic acid of the nucleic acid probe trans-cleaved by the Cas protein.
[0107] In another preferred embodiment, the length of the oligonucleotide (oligo) or oligonucleotide analogue complementary to the second and fourth Cas protein trans-cleavage reporter molecules is 10-50 nt, preferably 15-40 nt, and more preferably 15-30 nt.
[0108] In another preferred embodiment, the length of the single-stranded nucleic acid molecule or single-stranded nucleic acid analog molecule in the trans-cleavage reporter molecule of the first, second, third and fourth Cas proteins is 5-50 nt, preferably 15-40 nt, and more preferably 15-30 nt.
[0109] In another preferred embodiment, the nucleic acid probe includes single-stranded DNA or single-stranded RNA.
[0110] In another preferred embodiment, the nucleic acid probe comprises single-stranded DNA or single-stranded RNA with a detectable label.
[0111] In another preferred embodiment, the single-stranded DNA is fluorescent and biotin-labeled single-stranded DNA or single-stranded RNA.
[0112] In another preferred embodiment, the single-stranded DNA is fluorescently labeled single-stranded DNA or single-stranded RNA.
[0113] In another preferred embodiment, the length of the first guide RNA is 30-60 nt, preferably 35-45 nt, and more preferably 39-41 nt.
[0114] In another preferred embodiment, the length of the second guide RNA is 70-200 nt, preferably 90-150 nt, and more preferably 100-120 nt.
[0115] In another preferred embodiment, the length of the third guide RNA is 40-100 nt, preferably 50-80 nt, and more preferably 55-70 nt.
[0116] In another preferred embodiment, the length of the fourth guide RNA is 40-100 nt, preferably 50-80 nt, and more preferably 55-70 nt.
[0117] In another preferred embodiment, the detection includes: qualitative detection or quantitative detection.
[0118] In another preferred embodiment, the detection system further contains (e) a buffer solution.
[0119] In another preferred embodiment, the detection system further comprises reagents for amplification reactions of the first target sequence, the second target sequence, the third target sequence, and the fourth target sequence.
[0120] In another preferred embodiment, the amplification reaction of the first target sequence, the second target sequence, the third target sequence, and the fourth target sequence is selected from the group consisting of: PCR (Polymerase Chain Reaction Amplification), LAMP (Loop-mediated isothermal amplification), RPA (Recombinase Polymerase Amplification), LCR (Ligase Chain Reaction), bDNA (branched DNA Amplification), NASBA (Nuclear Acid Sequence-Based Amplification), SDA (Strand Displacement Amplification), TMA (Transcription-Mediated Amplification), RCA (Rolling Circle Amplification), HDA (Helicase-Dependent Amplification), SPIA (Single Primer Isothermal Amplification), NEAR (Nicking Enzyme Amplification), Reaction, nickase amplification reaction), SMAP (Smart Amplification Process, intelligent amplification method), SMAP2 (Smart Amplification Process version 2, second version of the intelligent amplification method), CPA (Cross Priming Amplification, cross primer amplification), MDA (Multiple Displacement Amplification, multiple displacement amplification), RAM (Ramification), cHDA (circular Helicase-Dependent Amplification,Helicase-dependent circular amplification), SMART (Signal Mediated Amplification of RNA Technology), 3SR (Self-Sustained Sequence Replication), GEAR (Genome Exponential Amplification Reaction), IMDA (Isothermal Multiple Displacement Amplification), ERA (Enzymatic Recombinase Amplification), TAS (Transcription-based amplification system), or a combination thereof.
[0121] In another preferred embodiment, the concentration of the first target sequence, the second target sequence, the third target sequence, and the fourth target sequence in the detection system is independently 0.01-10 8 copies / μl, preferably 0.1-100 copies / μl, more preferably 0.1-10 copies / μl.
[0122] In another preferred embodiment, the concentration of Cas protein, guide RNA, trans-cleavage reporter molecule, oligonucleotide or oligonucleotide analog is independently 25nM-5000nM, preferably 250nM-2500nM, and more preferably 500nM-1000nM.
[0123] In another preferred example, the V-type Cas protein other than the VB-type Cas protein is selected from the following group: VA-type Cas protein, VC-type Cas protein, VD-type Cas protein, VE-type Cas protein, VF-type Cas protein, VG-type Cas protein, VH-type Cas protein, VI-type Cas protein, VJ-type Cas protein, VL-type Cas protein, VM-type Cas protein, or a combination thereof. Preferably, the V-type Cas protein other than the VB-type Cas protein is selected from the following group: Cas12a, Cas12c, Cas12d, Cas12e, Cas12f, Cas12g, Cas12h, Cas12i, Cas12j, Cas12l, Cas12m, or a combination thereof.
[0124] In another preferred embodiment, the V-type Cas protein other than the VB-type Cas protein is a VA-type Cas protein, and preferably, the VA-type Cas protein is Cas12a.
[0125] In another preferred embodiment, the Cas12a is selected from the following group: FnCas12a, AsCas12a, LbCas12a, Lb5Cas12a, HkCas12a, OsCas12a, TsCas12a, BbCas12a, BoCas12a, Lb4Cas12a, CeCas12a, PrCas12a, CsbCas12a, BhCas12a, SsCas12a, Lb3Cas12a, BpCas12a, PdCas12a, BfCas12a, PcCas12a, cMtCas12a, PeCas12a, LiCas12a, Lb2Cas12a, PmCas12a, MbCas12a, EeCas12a, CsbCas12a, ErCas12a, ArCas12a, BsCas12a, AbCas12a or a combination thereof.
[0126] In another preferred embodiment, the source of Cas12a is selected from the group consisting of Leptotrichia, Listeria, Corynebacterium, Sutterella, Legionella, Treponema, Linebacteria, Eubacterium, Streptococcus, Lactobacillus, Mycoplasma, Bacteroides, Flaviivola, Flavobacterium, Azospirillum, Sphaerochaeta, Gluconacetobacter, Neisseria, Roseburia, Parvibaculum, Staphylococcus, Nitratifractor, Mycoplasma, Campylobacter, Lachnospira, or a combination thereof.
[0127] In another preferred embodiment, the source of Cas12a is selected from the group consisting of Francisella tularensis (FnCas12a), Acidaminococcus sp. BV3L6 (AsCas12a), Lachnospiraceae bacterium ND2006 (LbCas12a), Lachnospiraceae bacterium NC2008 (Lb5Cas12a), Helcococcus sp kunzii (HkCas12a), Oribacterium sp. NK2B42 (OsCas12a), Thiomicrospira sp. XS5 (TsCas12a), Bacteroides KA00251 (BbCas12a), Bacteroides oralis (Bacteroidetes oral taxon 274)(BoCas12a), Lachnospiraceae bacterium MC2017(Lb4Cas12a), Coprococcus eutactus(CeCas12a), Prevotella ruminicola strain BPI-34(PrCas12a), Candidatus Saccharibacteria bacterium(CsbCas12a), Butyrivibrio hungatei strain MB2003(BhCas12a), Smithella sp.SC_K08D17)(SsCas12a), Lachnospiraceae bacterium MC2017(Lb3Cas12a), Bytyrivibrio proteoclasticus(BpCas12a), Prevotella disens(PdCas12a), Butyrivibrio fibrisolvens MD2001(BfCas12a), Porphyromonas crevioricanis PcCas12a, Candidatus Methanoplasma termitum(CMtCas12a), Peregrinibacteria bacterium(PeCas12a), Leptospira inadaiserovar Lyme(LiCas12a), Lachnospiraceae MA2020(Lachnospiraceae bacterium MA2020)(Lb2Cas12a), Porphyromonas macaca (PmCas12a), Moraxella bovoculi 237 (MbCas12a), Eubacterium eligens (EeCas12a), Candidatus Saccharibacteria bacterium (CsbCas12a), Eubacterium rectal (ErCas12a), Agathobacter rectalis strain (ArCas12a), Butyrivibrio sp. NC3005 (BsCas12a), Arcobacter butzleri (AbCas12a), or a combination thereof.
[0128] In another preferred embodiment, the VB type Cas protein includes Cas12b.
[0129] In another preferred embodiment, the source of Cas12b is selected from the following group: Alicyclobacillus kakegawensis, Bacillus V3-13 species, Bacillus hisashii, Lentisphaeria bacterium, Laceyella sediminis, Brevibacillus sp. or a combination thereof.
[0130] In another preferred embodiment, the Cas12b is selected from the following group: AacCas12b, AaCas12b, BthCas12b, AapCas12b, AkCas12b, AmCas12b, Bs3Cas12b, LsCas12b, BrCas12b or a combination thereof.
[0131] In another preferred embodiment, the third type VI Cas protein or the fourth type VI Cas protein each independently includes Cas13.
[0132] In another preferred embodiment, the Cas13 is selected from the following group: Cas13a, Cas13b, Cas13c, Cas13d, Cas13e, Cas13f, Cas13x, Cas13y or a combination thereof.
[0133] In another preferred embodiment, the Cas13 protein is or is derived from the following species: Alistipes, Anaerosalibacter, Bacteroides, Bacteroidetes, Bergeyella, Blautia, Butyrivibrio, Capnocytophaga, Carnobacterium, Chloroflexus, Chryseobacterium, Clostridium, Demequina, Eubacteriaceae, Eubacterium, Flavobacterium, Fusobacterium, Herbinix, Insolitispirillum, Lachnospiraceae, Leptotrichia, Listeria, Myroides, Paludibacter, Phaeodactylibacter, Porphyromonadaceae, Porphyromonas, Prevotella, Pseudobutyrivibrio, Psychroflexus, Reichenbachiella, Rhodobacter, Riemerella, Sinomicrobium, Thalassospira, Ruminococcus; preferably, Leptotrichia shahii, Listeria seeligeri), Lachnospiraceae bacteria (such as Lb MA2020, Lb NK4A179, Lb NK4A144), Clostridium aminophilum (such as CaDSM 10710), Carnobacterium gallinarum (such as Cg DSM 4847), Propionibacterium propionicigenes (such as PpWB4), Listeria weihenstephanensis (such as Lw FSL R9-0317), Listeriaceae bacterium (such as Lb FSL M6-0635), Leptotrichia wadei (such as Lw F0279), Rhodobacter capsulatus (such as Rc SB 1003, Rc R121, Rc DE442), Leptotrichia buccalis (such as Lb C-1013-b), Herbinix hemicellulosilytica, Eubacteriaceae bacterium (such as Eb CHKCI004), Blautia sp. Marseille-P2398, Leptotrichia sp.) oral taxa 879str.F0557, Chloroflexus aggregans, Demequina aurantiaca, Thalassospira sp. TSL5-1, Pseudobutyrivibrio sp. OR37, Butyrivibrio sp. YAB3001, Leptotrichia sp. Marseille-P3007, Bacteroides ihuae, Porphyromonadaceae bacteria (e.g., PbKH3CP3RA), Listeria riparia, Insolitispirillum peregrinum, Alistipes sp. ZOR0009, Bacteroides pyogenes (e.g., Bp F0041), Bacteroidetes bacterium (such as Bb GWA2_31_9), Bergeyella zoohelcum (such as Bz ATCC 43767), Capnocytophaga canimorsus, Capnocytophaga cynodegmi, Chryseobacterium carnipullorum, Chryseobacterium jejuensis (such as Chryseobacteriumjejuense), Chryseobacterium ureilyticum, Flavobacterium branchiophilum, Flavobacterium columnare, Flavobacterium sp. 316, Myroides odoratimimus (e.g., Mo CCUG 10230, Mo CCUG 12901, Mo CCUG 3837), Paludibacter propionicigenes, Phaeodactylibacter xiamenensis, Porphyromonas gingivalis (e.g., Pg F0185, Pg F0568, Pg JCVI SC001, Pg W4087), ... gulae), Porphyromonas sp. COT-052OH4946, Prevotella aurantiaca, Prevotella buccae (e.g., Pb ATCC 33574), Prevotella falsenii, Prevotella intermedia (e.g., Pi 17, Pi ZT), Prevotella pallens (e.g., Pp ATCC 700821), Prevotella pleuritidis, Prevotella saccharolytica (e.g., Ps F0055), Prevotella sp. MA2016, Prevotella sp. MSX73, Prevotella sp. P4-76, Prevotella sp.) P5-119, Prevotellasp. P5-125, Prevotella sp. P5-60, Psychroflexus torquis, Reichenbachiella agariperforans, Riemerella anatipestifer, Sinomicrobium oceani, Fusobacterium necrophorum (such as Fn subsp. funduliforme ATCC51357, FnDJ-2, Fn BFTR-1, Fn subsp. Funduliforme), Fusobacterium perfoetens (e.g., Fp ATCC 29250), Fusobacterium ulcerans (e.g., Fu ATCC 49185), Anaerosalibacter sp. ND1, Eubacterium siraeum, Ruminococcus flavefaciens (e.g., Rfx XPD3002), Ruminococcus albus, or a combination thereof.
[0134] In another preferred embodiment, the system is one of the following:
[0135] a composition, product combination, reagent, or kit;
[0136] Instruments and equipment containing the aforementioned compositions, product combinations, reagents or kits;
[0137] A mixture formed when the aforementioned composition, product combination, reagent, or kit is used for detection;
[0138] Apparatus containing the aforementioned mixture.
[0139] A sixth aspect of the present invention provides a kit for detecting a target nucleic acid molecule, the kit comprising:
[0140] Containers No. 1 to N and nucleic acid detection compositions No. 1 to N located in the containers No. 1 to N, the nucleic acid detection compositions No. 1 to N comprising corresponding Cas proteins No. 1 to N, corresponding guide RNAs No. 1 to N, corresponding Cas protein trans-cleavage reporter molecules No. 1 to N and corresponding oligonucleotides No. 1 to N or oligonucleotide analogs; the Cas protein is a V-type Cas protein; the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N is higher than the trans-cleavage activity temperature of the Cas protein in the nucleic acid detection composition No. N-1. Or inactivation temperature, the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-1 is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-2, and so on, the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of this number is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of the previous number, except when N=1; the guide RNA Nos. 1 to N include direct repeats (Direct repeats) that can bind to the corresponding Cas proteins Nos. 1 to N Repeat, DR) sequence and a guide sequence capable of targeting the corresponding target sequences 1 to N; the 1st to Nth Cas protein trans-cleavage reporter molecules include the corresponding 1st to Nth single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules, and the 1st to Nth single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules do not hybridize with the guide sequence of the guide RNA in the system; and the 1st to Nth oligonucleotides or oligonucleotide analogs can be complementary to the corresponding 1st to Nth Cas protein trans-cleavage reporter molecules to form 1st to Nth blocked Cas protein trans-cleavage reporter molecules, and the trans-cleavage activity temperature of the 1st to Nth Cas proteins matches the melting temperature of the corresponding 1st to Nth blocked Cas protein trans-cleavage reporter molecules; wherein N is a positive integer ≥1, preferably, N is 1-20, more preferably, N is 1-15, and more preferably, N=1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11;
[0141] and / or
[0142] Containers No. 1' to N' and nucleic acid detection compositions No. 1' to N' located in the containers No. 1' to N', the nucleic acid detection compositions No. 1' to N' comprising corresponding Cas proteins No. 1' to N', corresponding guide RNAs No. 1' to N', corresponding Cas protein trans-cleavage reporter molecules No. 1' to N', and corresponding oligonucleotides No. 1' to N' or oligonucleotide analogs; the Cas protein is a type VI Cas protein; the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N' is higher than the trans-cleavage activity temperature of the Cas protein in the nucleic acid detection composition No. N'-1. The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-1 is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-2, and so on. The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of this number is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of the previous number, except when N'=1'; the guide RNA No. 1' to N' includes a direct repeat (Direct repeat) capable of binding to the corresponding Cas protein No. 1' to N' Repeat, DR) sequence and a guide sequence capable of targeting the corresponding 1' to N' target sequence; the 1' to N' Cas protein trans-cutting reporter molecule includes the corresponding 1' to N' single-stranded nucleic acid molecule or single-stranded nucleic acid analog molecule, and the 1' to N' single-stranded nucleic acid molecule or single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system; and the 1' to N' oligonucleotide or oligonucleotide analog can trans-cut with the corresponding 1' to N' Cas protein The reporter molecules are complementary to each other and can form trans-cleavage reporter molecules of the blocked Cas proteins No. 1' to N', and the trans-cleavage activity temperature of the Cas proteins No. 1' to N' matches the melting temperature of the corresponding trans-cleavage reporter molecules of the blocked Cas proteins No. 1' to N'; wherein N' is a positive integer ≥1', preferably, N' is 1'-20', more preferably, N' is 1'-15', and more preferably, N'=1', 2', 3', 4', 5', 6', 7', 8', 9', 10' or 11'.
[0143] In another preferred example, the oligonucleotides No. 1 to N or oligonucleotide analogs are complementary to the corresponding single-stranded nucleic acid molecules No. 1 to N or single-stranded nucleic acid analog molecules of the corresponding Cas protein trans-cleavage reporter molecules No. 1 to N to form closed Cas protein trans-cleavage reporter molecules.
[0144] In another preferred example, the 1' to N' oligonucleotides or oligonucleotide analogs are complementary to the corresponding 1' to N' single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules of the corresponding 1' to N' Cas protein trans-cleavage reporter molecules to form closed Cas protein trans-cleavage reporter molecules.
[0145] In another preferred embodiment, the kit for detecting a target nucleic acid molecule further comprises:
[0146] a) an Mth container and an Mth nucleic acid detection composition located in the Mth container, wherein the Mth nucleic acid detection composition comprises:
[0147] The Mth Cas protein, wherein the Mth Cas protein is a V-type Cas protein, preferably a VA-type Cas protein, more preferably Cas12a;
[0148] An Mth guide RNA, comprising a direct repeat (DR) sequence capable of binding to an Mth Cas protein and a guide sequence capable of targeting an Mth target sequence; and
[0149] The Mth Cas protein trans-cleaves the reporter molecule, wherein the Mth Cas protein trans-cleaves the reporter molecule including the Mth single-stranded nucleic acid molecule or the Mth single-stranded nucleic acid analog molecule, and the Mth single-stranded nucleic acid molecule or the Mth single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system;
[0150] and / or
[0151] An M'th container and an M'th Cas protein located in the M'th container, wherein the M'th Cas protein is a type VI Cas protein, preferably a type VI-A Cas protein, more preferably Cas13a;
[0152] an M'th guide RNA, wherein the M'th guide RNA comprises a direct repeat (DR) sequence capable of binding to the M'th Cas protein and a guide sequence capable of targeting the M'th target sequence; and
[0153] The M'Cas protein trans-cleaves the reporter molecule, wherein the M'Cas protein trans-cleaves the reporter molecule, comprising the M' single-stranded nucleic acid molecule or the M' single-stranded nucleic acid analog molecule, wherein the M' single-stranded nucleic acid molecule or the M' single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system;
[0154] The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. 1 to No. N is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. M;
[0155] The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection compositions No. 1' to N' is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. M'.
[0156] In another preferred embodiment, the kit further comprises a buffer solution.
[0157] A seventh aspect of the present invention provides a kit for multiplex detection of target nucleic acid molecules, the kit comprising:
[0158] i) a first container and a first nucleic acid detection composition within the first container, wherein the first nucleic acid detection composition comprises a first V-type Cas protein and a first guide RNA, wherein the first guide RNA comprises a direct repeat (DR) sequence capable of binding to the first V-type Cas protein and a guide sequence capable of targeting a first target sequence, and the first V-type Cas protein is a V-type Cas protein other than a VB-type Cas protein;
[0159] ii) a second container and a second nucleic acid detection composition located in the second container, the second nucleic acid detection composition comprising a second V-type Cas protein and a second guide RNA, the second guide RNA comprising a direct repeat (DR) sequence capable of binding to the second V-type Cas protein and a guide sequence capable of targeting a second target sequence; the trans-cleavage activity temperature or inactivation temperature of the second V-type Cas protein is higher than the trans-cleavage activity temperature or inactivation temperature of the first V-type Cas protein, and the second V-type Cas protein is a VB-type Cas protein;
[0160] iii) an optional third container and a third nucleic acid detection composition located within the third container, the third nucleic acid detection composition comprising a third type VI Cas protein and a third guide RNA, the third guide RNA comprising a direct repeat (DR) sequence capable of binding to the third type VI Cas protein and a guide sequence capable of targeting a third target sequence, the third type VI Cas protein being a type VI Cas protein other than a thermostable type VI Cas protein;
[0161] iv) an optional fourth container and a fourth nucleic acid detection composition located in the fourth container, the fourth nucleic acid detection composition comprising a fourth type VI Cas protein and a fourth guide RNA, the fourth guide RNA comprising a direct repeat (DR) sequence capable of binding to the fourth type VI Cas protein and a guide sequence capable of targeting a fourth target sequence, the trans-cleavage activity temperature or inactivation temperature of the fourth type VI Cas protein being higher than the trans-cleavage activity temperature or inactivation temperature of the third type VI Cas protein, and the fourth type VI Cas protein being a heat-stable type VI Cas protein;
[0162] v) a fifth container and a first, second, optional third, and optional fourth Cas protein trans-cleavage reporter molecule located in the fifth container, wherein the first, second, optional third, and optional fourth Cas protein trans-cleavage reporter molecule each independently has a single-stranded nucleic acid molecule or a single-stranded nucleic acid analog molecule that does not hybridize with the guide sequence of the guide RNA in the kit;
[0163] vi) a sixth container and a complementary oligonucleotide (oligo) or oligonucleotide analog of a second Cas protein trans-cleavage reporter molecule located in the sixth container, and an optional complementary oligonucleotide (oligo) or oligonucleotide analog of a fourth Cas protein trans-cleavage reporter molecule; the second Cas protein trans-cleavage reporter molecule and the optional fourth Cas protein trans-cleavage reporter molecule each independently form a second blocked Cas protein trans-cleavage reporter molecule and an optional fourth blocked Cas protein trans-cleavage reporter molecule with their corresponding oligonucleotides or oligonucleotide analogs, and the melting temperature of the second blocked Cas protein trans-cleavage reporter molecule matches the trans-cleavage activity temperature of the second V-type Cas protein; the melting temperature of the fourth Cas protein trans-cleavage reporter molecule matches the trans-cleavage activity temperature of the fourth VI-type Cas protein.
[0164] In another preferred embodiment, any two, three, four, five, or six (or all) of the first container, second container, third container, fourth container, fifth container, and sixth container may be the same (or identical) or different containers.
[0165] In another preferred embodiment, the fifth container and the sixth container are the same container, and the second Cas protein trans-cleavage reporter molecule or the optional fourth Cas protein trans-cleavage reporter molecule and its corresponding oligonucleotide (oligo) or oligonucleotide analog are combined or not combined together.
[0166] In another preferred embodiment, any two, three, four, five or six (or all) of the first container, second container, third container, fourth container, fifth container and sixth container may be the same (or identical) or different containers.
[0167] In another preferred embodiment, the kit further comprises a buffer solution.
[0168] In another preferred embodiment, the first target sequence is derived from an internal reference gene, selected from the group consisting of an RP internal reference gene, a GAPDH internal reference gene, a β-actin internal reference gene, or a combination thereof.
[0169] An eighth aspect of the present invention provides a method for detecting a target nucleic acid molecule, the method comprising subjecting a sample to be detected to the following reaction:
[0170] i) contacting the sample to be tested with the detection system for detecting target nucleic acid molecules according to the fourth aspect of the present invention, and reacting at a first detection temperature;
[0171] ii) detecting a detectable signal generated by the trans-cleavage reporter molecule No. 1 and / or the trans-cleavage reporter molecule No. 1' by the Cas protein in the detection system, thereby detecting the target sequence No. 1 corresponding to the trans-cleavage reporter molecule No. 1 and / or the target sequence No. 1' corresponding to the trans-cleavage reporter molecule No. 1' by the Cas protein;
[0172] iii) gradually increasing the temperature, gradually allowing the next closed Cas protein trans-cleavage reporter molecule to release the corresponding Cas protein trans-cleavage reporter molecule and inactivating the current Cas protein, and detecting the detectable signal generated by the next Cas protein trans-cleavage reporter molecule (for example, allowing the closed Cas protein trans-cleavage reporter molecule in the nucleic acid detection composition No. N to release the corresponding Cas protein trans-cleavage reporter molecule and inactivate the Cas protein No. N-1, allowing the closed Cas protein trans-cleavage reporter molecule in the nucleic acid detection composition No. N-1 to release the corresponding Cas protein trans-cleavage reporter molecule and inactivate the Cas protein No. N-2, and so on, except when N=1), thereby detecting the corresponding target sequence.
[0173] In another preferred example, the method for detecting the target nucleic acid molecule further includes performing a reaction at the Mth detection temperature, detecting a detectable signal generated by the Mth Cas protein trans-cutting reporter molecule and / or the M'Cas protein trans-cutting reporter molecule in the detection system, thereby detecting the Mth target sequence corresponding to the Mth Cas protein trans-cutting reporter molecule and / or the M' target sequence corresponding to the M'Cas protein trans-cutting reporter molecule; the obtained Mth detection temperature is lower than the first detection temperature, and the Mth Cas protein and / or the M'Cas protein is inactivated at the first temperature.
[0174] A ninth aspect of the present invention provides a method for multiplex detection of target nucleic acid molecules, the method comprising subjecting a sample to be detected to the following reaction:
[0175] i) contacting the sample to be detected with the multiplex detection system for detecting target nucleic acid molecules as described in the fifth aspect of the present invention, and reacting at a first temperature;
[0176] ii) detecting a detectable signal generated by the trans-cleavage of the reporter molecule by the first Cas protein, and optionally the trans-cleavage of the reporter molecule by the third Cas protein in the detection system, thereby detecting the first and / or third target sequence;
[0177] iii) carrying out the reaction at a second temperature;
[0178] iv) detecting a detectable signal generated by the second Cas protein trans-cleaving the reporter molecule, optionally the fourth Cas protein trans-cleaving the reporter molecule, thereby detecting the second target sequence and / or the fourth target sequence, wherein the first temperature is lower than the second temperature.
[0179] In another preferred embodiment, the first temperature is 20-50°C, preferably 30-40°C.
[0180] In another preferred embodiment, the second temperature is 50-80°C, preferably 55-70°C.
[0181] In another preferred embodiment, the sample can be a single sample or a mixed sample.
[0182] In another preferred embodiment, the sample to be detected includes a non-amplified sample and an amplified (or nucleic acid amplified) sample.
[0183] In another preferred embodiment, the sample to be detected is a sample obtained by amplification.
[0184] In another preferred embodiment, the sample is derived from a sample obtained by a culture method selected from the group consisting of cell culture, bacterial culture, viral culture, fungal culture, microbial culture, organoid culture, animal in vivo enrichment culture, and plant culture.
[0185] In another preferred embodiment, the nucleic acid amplification method is selected from the following group: PCR (Polymerase Chain Reaction Amplification), LAMP (Loop-mediated isothermal amplification), RPA (Recombinase Polymerase Amplification), LCR (Ligase Chain Reaction), bDNA (branched DNA Amplification), NASBA (Nuclear Acid Sequence-Based Amplification), SDA (Strand Displacement Amplification), TMA (Transcription-Mediated Amplification), RCA (Rolling Circle Amplification), HDA (Helicase-Dependent Amplification), SPIA (Single Primer Isothermal Amplification), NEAR (Nicking Enzyme Amplification Reaction), SMAP (Smart Amplification Process (smart amplification process), SMAP2 (Smart Amplification Process version 2), CPA (Cross Priming Amplification), MDA (Multiple Displacement Amplification), RAM (Ramification), cHDA (circular Helicase-Dependent Amplification,Helicase-dependent circular amplification), SMART (Signal Mediated Amplification of RNA Technology), 3SR (Self-Sustained Sequence Replication), GEAR (Genome Exponential Amplification Reaction), IMDA (Isothermal Multiple Displacement Amplification), ERA (Enzymatic Recombinase Amplification), TAS (Transcription-based amplification system), or a combination thereof.
[0186] In another preferred embodiment, the method is used to detect whether the nucleic acid at the target site has a SNP, point mutation, deletion, and / or insertion.
[0187] In another preferred embodiment, the method is used to simultaneously detect multiple target nucleic acid molecules or multiple target genes of a target molecule.
[0188] In another preferred embodiment, the detection in step (ii) or (iii) includes fluorescence detection method and colloidal gold method.
[0189] In another preferred embodiment, the detection in step (ii) or (iii) includes a detection method based on gold nanoparticles, a detection method based on fluorophores, a detection method based on fluorescence polarization, a detection method based on colloidal phase change / dispersion, a detection method based on electrochemical signals, a detection method based on semiconductor signals, and a color-based detection method.
[0190] In another preferred embodiment, the fluorescence detection method is performed using an enzyme-labeled instrument or a fluorescence spectrophotometer.
[0191] In another preferred embodiment, the method is an in vitro method.
[0192] In another preferred embodiment, the method is a one-tube multiplex method.
[0193] In another preferred embodiment, the method is non-diagnostic and non-therapeutic.
[0194] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features described in detail below (such as in the embodiments) can be combined with each other to form new or preferred technical solutions. Due to space limitations, they will not be listed here one by one. BRIEF DESCRIPTION OF THE DRAWINGS
[0195] Figure 1 shows the fluorescence channel curve of LbCas12a detecting RP internal reference FAM.
[0196] Figure 2 shows the fluorescence channel curve of AapCas12b detecting the COVID-19 N gene ROX.
[0197] Figure 3 shows the fluorescence curves of Cas12a / Cas12b dual detection of COVID-19 N gene and RP internal reference.
[0198] Figure 4 shows the fluorescence channel curve of LbCas12a detecting RP internal reference FAM.
[0199] Figure 5 shows the fluorescence channel curve of AapCas12b detecting the COVID-19 N gene ROX.
[0200] Figure 6 shows the fluorescence curves of Cas12a / Cas12b dual detection of COVID-19 N gene and RP internal reference.
[0201] Figure 7 shows the fluorescence channel curve of LbCas12a detecting RP internal reference FAM.
[0202] Figure 8 shows the VIC fluorescence channel curve of LwaCas13a detecting the COVID-19 ORF1ab gene.
[0203] Figure 9 shows the fluorescence channel curve of AapCas12b detecting the COVID-19 N gene ROX.
[0204] Figure 10 shows the fluorescence curves of Cas12a / Cas12b / Cas13 multiplex detection of COVID-19 ORF1ab gene, N gene and RP internal reference.
[0205] Figure 11 shows the sensitivity test of Cas12a / Cas12b / Cas13 multiplex detection of COVID-19 virus: RP internal reference fluorescence curve.
[0206] Figure 12 shows the sensitivity test of Cas12a / Cas12b / Cas13 multiplex detection of COVID-19 virus: VIC fluorescence channel curve of COVID-19 ORF1ab gene.
[0207] Figure 13 shows the sensitivity test of Cas12a / Cas12b / Cas13 multiplex detection of COVID-19 virus: COVID-19 N gene VIC fluorescence channel curve.
[0208] Figure 14 shows a fluorescence curve graph of the sensitivity test results of Cas12a / Cas12b / Cas13 multiplex detection of COVID-19 virus.
[0209] Figure 15 is a schematic diagram of the formation of a DNA double strand by Cas12b-Reporter1 and CS-Cas12b-Oligo1.
[0210] Figure 16 is a schematic diagram of the formation of a DNA double strand by Cas12b-Reporter2 and CS-Cas12b-Oligo2. DETAILED DESCRIPTION
[0211] After extensive and in-depth research, the inventors of the present application have developed for the first time a detection system for detecting target nucleic acid molecules, which can realize a multiple detection system (the system should be understood in a broad sense and can be a composition, product combination, reagent, kit, or an instrument containing the aforementioned composition, product combination, reagent, kit, or a mixture formed when the composition, product combination, reagent, kit is used for detection, as well as an instrument containing the aforementioned mixture, etc.). The present invention utilizes different models of V-type Cas proteins with different optimum temperatures for trans-cleavage activity or different inactivation temperatures, and the closed Cas protein reporter molecules formed by oligonucleotides or oligonucleotide analogs and V-type Cas protein trans-cleavage reporter molecules can be designed to melt at the corresponding Cas protein trans-cleavage activity temperature (unzipped into a linear single chain by a double-stranded or hairpin-type), overcoming the shortcomings of different models of V-type Cas proteins in trans-cleavage without specificity, achieving different models of V-type Cas proteins to detect a variety of different target nucleic acid molecules in one tube, and can obtain very high detection sensitivity and specificity, and the detection system of the present invention is based on the multiple detection system of different models of V-type Cas proteins, and can also be compatible with the detection system of VI-type Cas proteins, further combined into V-type Cas and VI-type Cas protein multiple detection systems. On this basis, the inventors have completed the present invention.
[0212] the term
[0213] Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art.
[0214] The term "oligonucleotide" refers to a sequence containing 10-50 nucleotides, preferably, 15-40 nucleotides, more preferably, 15-30 nucleotides.
[0215] The term "oligonucleotide analogue" refers to a sequence containing 10-50 nucleotide analogues, preferably 15-40 nucleotide analogues, more preferably 15-30 nucleotide analogues. The term "oligonucleotide analogue" includes sequences that are partially nucleotide analogues and sequences that are entirely nucleotide analogues.
[0216] As used herein, the term "CRISPR" refers to Clustered regularly interspaced short palindromic repeats, which are derived from the immune system of microorganisms.
[0217] As used herein, "biotin," also known as vitamin H, is a small molecule vitamin with a molecular weight of 244 Da. Biotin's extremely strong affinity can be used to amplify or enhance detection signals in detection systems. For example, biotin readily covalently binds to proteins (such as antibodies). Enzyme-bound avidin molecules react with biotin molecules bound to specific antibodies, achieving both multi-stage amplification and color development due to the enzyme's catalytic action upon encountering the corresponding substrate, thereby enabling the detection of unknown antigen (or antibody) molecules.
[0218] CRISPR-Cas: A unique genomic element derived from bacteria and archaea that acts as an adaptive immune defense system to protect against invading phages or foreign nucleic acids. The system consists of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas proteins, or Cas).
[0219] Limit of Detection (LOD): The lowest concentration of an analyte in a sample that can be consistently detected with a typical probability of 95% certainty.
[0220] Cycle Threshold (Ct) Value: The number of cycles required for the fluorescence signal to exceed background levels in a PCR reaction. The Ct value is inversely proportional to the amount of target nucleic acid in the sample (i.e., the lower the Ct level, the greater the amount of target nucleic acid in the sample). A Ct value of 36 or less is clearly positive. Questionable, indeterminate, or weakly positive results show Ct values between 37 and 40. This may indicate early or late infection, or environmental contamination.
[0221] The term "Cas protein" refers to a CRISPR-associated protein, which is an associated protein in the CRISPR system.
[0222] The term "Cas12a" (formerly known as "Cpf1") refers to a crRNA-dependent endonuclease, which is a type VA enzyme in the CRISPR system classification.
[0223] The terms "Cas12b" and "C2c1" are used interchangeably to refer to the sgRNA-dependent endonuclease, which is a type VB enzyme in the CRISPR system classification.
[0224] The term "PAM" refers to the protospacer-adjacent motif, which is a short DNA sequence directly adjacent to the DNA sequence targeted by the CRISPR effector protein. It is required for Cas12a or Cas12b to cut double-stranded DNA. For example, the PAM of Cas12a is TTTV, and the PAM of AacCas12b is TTN sequence.
[0225] The term "target DNA or RNA molecule" refers to the DNA or RNA to be detected or a specific portion thereof.
[0226] In the present invention, the melting temperature matches the trans-cleavage activity temperature, which means that at this temperature, the blocked Cas protein reporter molecule melts into a single chain, while the corresponding Cas protein still has trans-cleavage activity. The melting temperature of the blocked Cas protein reporter molecule is designed based on the fact that the Cas protein corresponding to the blocked Cas protein reporter molecule that melts at a relatively lower temperature has no trans-cleavage activity at this temperature.
[0227] Cas proteins
[0228] The "Cas protein" described herein refers to a CRISPR-associated protein (some documents translate it as CRISPR-Cas effector protein, CRISPR / Cas effector protein, CRISPR-Cas effector, CRISPR / Cas effector), which can be a V-type Cas protein or a VI-type Cas protein. Once the V-type Cas protein binds to a cis-cleavage substrate under the guidance of a guide RNA to form a ternary complex of Cas protein-guide RNA-cis-cleavage substrate, it can induce its trans-cleavage activity, i.e., randomly cleave single-stranded nucleic acids and their equivalents (nucleic acid equivalents such as nucleic acid analogs).
[0229] The Cas protein described in this specific embodiment is a protein with trans-cleavage activity.
[0230] The type VI Cas protein is Cas13.
[0231] The type VI Cas protein is selected from the group consisting of a type VI-A Cas protein, a type VI-B Cas protein, a type VI-D Cas protein, a type VI-X Cas protein, a type VI-Y Cas protein, or a combination thereof.
[0232] The type VI Cas protein is selected from the group consisting of Cas13a, Cas13b, Cas13c, Cas13d, Cas13e, Cas13f, Cas13x, Cas13y, or a combination thereof.
[0233] In some embodiments, the Cas13 protein is or is derived from the following species: Alistipes, Anaerosalibacter, Bacteroides, Bacteroidetes, Bergeyella, Blautia, Butyrivibrio, Capnocytophaga, Carnobacterium, Chloroflexus, Chryseobacterium, Clostridium, dium), Demeequina, Eubacteriaceae, Eubacterium, Flavobacterium, Fusobacterium, Herbinix, Insolitispirillum, Lachnospiraceae, Leptotrichia, Listeria, Myroides, Paludibacter, Phaeodactylibacter, Porphyromonadaceae, Porphyromonas, Prevotella, Pseudobutyrivibrio, Psychroflexus, Reichenbachiella, Rhodobacter, Riemerella, Sinomicrobium, Thalassospira, Ruminococcus; preferably, Leptotrichia shahii, Listeria seeligeri, Lachnospiraceae bacteria (such as Lb MA2020, Lb NK4A179, Lb NK4A144), Clostridium aminophilum (such as CaDSM 10710), Carnobacterium gallinarum (such as Cg DSM 4847), Propionibacterium propionicigenes) (such as PpWB4), Listeria weihenstephanensis (such as Lw FSL R9-0317), Listeriaceae bacterium (such as Lb FSL M6-0635), Leptotrichia wadei (such as Lw F0279), Rhodobacter capsulatus (such as Rc SB 1003, Rc R121, Rc DE442), Leptotrichia buccalis (such as Lb C-1013-b), Herbinix hemicellulosilytica, Eubacteriaceae bacterium (such as Eb CHKCI004), Blautia sp. Marseille-P2398, Leptotrichia sp.) oral taxa 879str.F0557, Chloroflexus aggregans, Demequina aurantiaca, Thalassospira sp. TSL5-1, Pseudobutyrivibrio sp. OR37, Butyrivibrio sp. YAB3001, Leptotrichias sp. Marseille-P3007, Bacteroides ihuae, Porphyromonadaceae bacteria (e.g., PbKH3CP3RA), Listeria riparia, Insolitispirillum peregrinum, Alistipes sp. ZOR0009, Bacteroides pyogenes (e.g., Bp F0041), Bacteroidetes bacterium (such as Bb GWA2_31_9), Bergeyella zoohelcum (such as Bz ATCC 43767), Capnocytophaga canimorsus, Capnocytophaga cynodegmi, Chryseobacterium carnipullorum, Chryseobacterium jejuensis (such as Chryseobacteriumjejuense), Chryseobacterium ureilyticum, Flavobacterium branchiophilum, Flavobacterium columnare, Flavobacterium sp. 316, Myroides odoratimimus (e.g., Mo CCUG 10230, Mo CCUG 12901, Mo CCUG 3837), Paludibacter propionicigenes, Phaeodactylibacter xiamenensis, Porphyromonas gingivalis (e.g., Pg F0185, Pg F0568, Pg JCVI SC001, Pg W4087), ... gulae), Porphyromonas sp. COT-052OH4946, Prevotella aurantiaca, Prevotella buccae (e.g., Pb ATCC 33574), Prevotella falsenii, Prevotella intermedia (e.g., Pi 17, Pi ZT), Prevotella pallens (e.g., Pp ATCC 700821), Prevotella pleuritidis, Prevotella saccharolytica (e.g., Ps F0055), Prevotella sp. MA2016, Prevotella sp. MSX73, Prevotella sp. P4-76, Prevotella sp.) P5-119, Prevotellasp. P5-125, Prevotella sp. P5-60, Psychroflexus torquis, Reichenbachiella agariperforans, Riemerella anatipestifer, Sinomicrobium oceani, Fusobacterium necrophorum (such as Fn subsp. funduliforme ATCC51357, FnDJ-2, Fn BFTR-1, Fn subsp. Funduliforme), Fusobacterium perfoetens (e.g., Fp ATCC 29250), Fusobacterium ulcerans (e.g., Fu ATCC 49185), Anaerosalibacter sp. ND1, Eubacterium siraeum, Ruminococcus flavefaciens (e.g., Rfx XPD3002), Ruminococcus albus, or a combination thereof.
[0234] In another preferred embodiment, the Cas13a protein is selected from the group consisting of LwaCas13a, LbaCas13a, LshCas13a, PprCas13a, EreCas13a, LneCas13a, CamCas s13a, RcaCas13a, HheCas13a, LbuCas13a, LseCas13a, LbmCas13a, LbnCas13a, RcsCas s13a, RcrCas13a, RcdCas13a, CgCas13a, Cg2Cas13a, LweCas13a, LbfCas13a, Lba4Cas s13a, Lba9Cas13a, LneCas13a, HheCas13a, RcaCas13a, or a combination thereof.
[0235] In another preferred embodiment, the Cas13a protein is selected from the following species: Bacteroides, Blautia, Butyrivibrio, Carnobacterium, Chloroflexus, Clostridium, Demequina, Eubacterium, Herbinix, Insolitispirillum, Lachnospiraceae, Leptotrichia, Listeria, Paludibacter, Porphyromonadaceae, Pseudobutyrivibrio, Rhodobacter or Thalassospira; preferably, Leptotrichia shahii, Listeria seeligeri), Lachnospiraceaebacterium (such as Lb MA2020, Lb NK4A179, Lb NK4A144), Clostridium aminophilum (such as CaDSM 10710), Carnobacterium gallinarum (such as Cg DSM 4847), Paludibacter propionicigenes (such as Pp WB4), Listeria weihenstephanensis (such as Lw FSL R9-0317), Listeriaceaebacterium (such as Lb FSL M6-0635), Leptotrichia wadei (such as Lw F0279), Rhodobacter capsulatus (such as Rc SB 1003, Rc R121, Rc DE442), Leptotrichia buccalis (such as Lb C-1013-b), Herbinix hemicellulosilytica, Eubacteriaceae bacterium (such as Eb CHKCI004), Blautia sp. Marseille-P2398, Leptotrichia sp.Oral taxa include: 879str.F0557, Chloroflexus aggregans, Demequina aurantiaca, Thalassospira sp. TSL5-1, Pseudobutyrivibrio sp. OR37, Butyrivibrio sp. YAB3001, Leptotrichias sp. Marseille-P3007, Bacteroides ihuae, Porphyromonadaceae bacteria (e.g., PbKH3CP3RA), Listeria riparia, or Insolitispirillum peregrinum.
[0236] In another preferred embodiment, the Cas13b is selected from the following group: Cas13b-t1, Cas13b-t2, Cas13b-t3, Cas13b-t4, Cas13b-t5, Cas13b-t6 or a combination thereof.
[0237] In another preferred embodiment, the Cas13b is selected from the following group: BzCas13b, PbCas13b, PspCas13b, RanCas13b, PguCas13b, PsmCas13b, CcaCas13b, AspCas13b, PauCas13b, Pin2Cas13b, Pin3Cas13b or a combination thereof.
[0238] In another preferred embodiment, the Cas13b is or is derived from the following species: Alistipes, Bacteroides, Bacteroidetes, Bergeyella, Capnocytophaga, Chryseobacterium, Flavobacterium, Myroides, Paludibacter, Phaeodactylibacter, Porphyromonas, Prevotella, Psychroflexus, Reichenbachiella, Riemerella or Sinomicrobium; preferably, Alistipes sp. ZOR0009, Bacteroides pyogenes (such as Bp F0041), Bacteroidetes bacterium (e.g., BbGWA2_31_9), Bergeyella zoohelcum (e.g., Bz ATCC 43767), Capnocytophaga canimorsus, Capnocytophaga cynodegmi, Chryseobacterium carnipullorum, Chryseobacterium jejuense, Chryseobacterium ureilyticum, Flavobacterium branchiophilum, Flavobacterium columnare, Flavobacterium sp.)316, Myroides odoratimimus (such as Mo CCUG 10230, Mo CCUG12901, Mo CCUG 3837), Paludibacter propionicigenes, Phaeodactylibacterxiamenensis, Porphyromonas gingivalis (such as Pg F0185, Pg F0568, PgJCVI SC001, Pg W4087), Porphyromonas gulae, Porphyromonas sp. COT-052OH4946, Prevotella aurantiaca, Prevotella buccae (such as Pb ATCC 33574), Prevotella falsenii, Prevotella intermedia intermedia) (e.g., Pi 17, Pi ZT), Prevotella pallens (e.g., Pp ATCC 700821), Prevotella pleuritidis, Prevotella saccharolytica (e.g., Ps F0055), Prevotella sp. MA2016, Prevotella sp. MSX73, Prevotella sp. P4-76, Prevotella sp. P5-119, Prevotella sp. P5-125, Prevotella sp. P5-60, Psychroflexus torquis, Reichenbachiella agariperforans, Riemerella anatipestifer, Sinomicrobium oceani or a combination thereof.
[0239] In another preferred embodiment, the Cas13c protein is or is derived from the following species: Fusobacterium or Anaerosalibacter; preferably, Fusobacterium necrophorum (such as Fn subsp. funduliforme ATCC 51357, Fn DJ-2, FnBFTR-1, Fn subsp. Funduliforme), Fusobacterium perfoetens (such as Fp ATCC29250), Fusobacterium ulcerans (such as Fu ATCC 49185), Anaerosalibacter sp. ND1 or a combination thereof.
[0240] In another preferred embodiment, the Cas13d is selected from the following group: RspCas13d, RfxCas13d, EsCas13d, AdmCas13d, or a combination thereof.
[0241] In another preferred embodiment, the Cas13d is derived from the following species: Eubacterium or Ruminococcus, preferably Eubacterium siraeum, Ruminococcus flavefaciens (such as Rfx XPD3002), Ruminococcus albus or a combination thereof.
[0242] The Cas protein described in this specific embodiment may be a V-type Cas protein; the Cas protein is selected from the following group: VA-type Cas protein, VB-type Cas protein, VC-type Cas protein, VD-type Cas protein, VE-type Cas protein, VF-type Cas protein, VG-type Cas protein, VH-type Cas protein, VI-type Cas protein, VJ-type Cas protein, VK-type Cas protein, VL-type, VM-type Cas protein or a combination thereof; the Cas protein described in this specific embodiment includes Cas12, such as Cas12a, Cas12b, Cas12c, Cas12d, Cas12e, Cas12f, Cas12g, Cas12h, Cas12i, Cas12j, Cas12l, Cas12m or a combination thereof.
[0243] In a specific embodiment, the Cas protein referred to herein has trans-cleavage activity, such as Cas12 or Cas13, and also covers functional variants of Cas proteins or their homologues or orthologues, such as the Cas12a mutant disclosed in Chinese invention patent application CN202210508434.7, which can be used in this specific embodiment. As used herein, the "functional variant" of a protein refers to a variant of such a protein that at least partially retains the trans-cleavage activity of the protein. Functional variants can include mutants (which can be insertions, deletions or substitutions), including polymorphs, etc. Functional variants also include fusion products of such proteins with another generally unrelated nucleic acid, protein, polypeptide or peptide. Functional variants can be naturally occurring or can be artificial. Advantageous embodiments can relate to engineered or non-naturally occurring V-type DNA targeting effector proteins.
[0244] In one embodiment, a V-type Cas protein, a VI-type Cas protein, or an ortholog thereof, or a homolog thereof, may comprise one or more mutations, and thus the nucleic acid molecule encoding the same may have one or more mutations. The mutation may be an artificially introduced mutation and may include, but is not limited to, one or more mutations in the catalytic domain.
[0245] In one embodiment, the V-type Cas protein can be from: Leptotrichia, Listeria, Corynebacterium, Sutterella, Legionella, Treponema, Trichoderma, Eubacterium, Streptococcus, Lactobacillus, Mycoplasma, Bacteroides, Flaviivola, Flavobacterium, Azospirillum, Sphaerochaeta, Gluconacetobacter, Neisseria, Roseburia, Parvibaculum, Staphylococcus, Nitratifractor, Mycoplasma, Campylobacter, Lachnospira, or a combination thereof.
[0246] Table 1 V-type family effector properties (source: doi:10.3389 / fcell.2020.622103)
[0247] a V stands for A, C, and G.
[0248] b R stands for A and G
[0249] C B stands for C, G and T.
[0250] guide RNA (gRNA)
[0251] As used herein, the "guide RNA" is a fusion of mature crRNA and tracrRNA as a guide RNA, or a fusion of mature crRNA and scoutRNA as a guide RNA, or crRNA alone as a guide RNA.
[0252] In general, a guide RNA may comprise direct repeat sequences (also known as DR sequences) and a guide sequence, or may consist essentially of or consist of direct repeat sequences and a guide sequence (also known as a spacer in the context of an endogenous CRISPR system). In different CRISPR systems, gRNA may include crRNA and tracrRNA, crRNA and scoutRNA, or only crRNA, depending on the Cas protein it relies on. crRNA and tracrRNA may be artificially modified and fused to form a single guide RNA (sgRNA). In some cases, the guide sequence is a polynucleotide sequence that has sufficient complementarity with the cis-cleavage substrate DNA to hybridize with the cis-cleavage substrate DNA and guide the specific binding of the CRISPR / Cas protein-guide RNA complex to the cis-cleavage substrate DNA, typically having a sequence length of 15-28 nt. The direct repeat sequence may fold to form a specific structure (such as a stem-loop structure) for recognition by the Cas protein to form a complex. The guide sequence does not need to be 100% complementary to the cis-cleavage substrate DNA. The guide sequence is not complementary to the nucleic acid in the trans-cleavage reporter molecule.
[0253] In certain embodiments, when optimally aligned, the degree of complementarity (match) between a guide sequence and its corresponding cis-cleavage substrate DNA is at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or at least 99%. Determining optimal alignment is within the capabilities of one of ordinary skill in the art. For example, there are publicly available and commercially available alignment algorithms and programs such as, but not limited to, ClustalW, the Smith-Waterman algorithm in Matlab, Bowtie, Geneious, Biopython, and SeqMan.
[0254] The terms "polynucleotide," "nucleotide sequence," "nucleic acid sequence," "nucleic acid molecule," and "nucleic acid" are used interchangeably and include DNA, RNA, or hybrids thereof, which may be double-stranded or single-stranded.
[0255] The terms "homology" or "identity" are used to refer to the matching of sequences between two polypeptides or between two nucleic acids. When a position in the two sequences being compared is occupied by the same base or amino acid monomer subunit (e.g., a position in each of the two DNA molecules is occupied by adenine, or a position in each of the two polypeptides is occupied by lysine), then the molecules are identical at that position between the two sequences. Typically, a comparison is made when the two sequences are aligned for maximum identity. Such an alignment can be determined using, for example, the identity of the amino acid sequence can be determined by conventional methods, with reference to, for example, Smith and Waterman, 1981, Adv. Appl. Math. 2: 482 Pearson & Lipman, 1988, Pro. Natl. Acad. Sci. USA 85: 244, Thompson et al., 1994, Nucleic Acids Res 22: 467-380, etc., by computerized operation of algorithms (GAP, BESTFIT, FASTA, and TFASTA, Genetics Computer Group in the Wisconsin Genetics software package). The BLAST algorithm available from the National Center for Biotechnology Information (NCBI www.ncbi.nlm.nih.gov / ) can also be used and determined using default parameters.
[0256] Nucleic acid analogs
[0257] Nucleic acid analogs are a class of derivatives of RNA and DNA. Nucleic acids are mainly composed of phosphate, pentose, and bases, while nucleic acid analogs replace at least one of these with other substances. The main nucleic acid analogs include peptide nucleic acid (PNA), morpholino (MNA), bridged nucleic acid (BNA), locked nucleic acid (LNA), glycol nucleic acid (GNA), and threose nucleic acid (TNA). Some of these nucleic acid analogs can even carry out biological processes such as replication and translation in vitro (Brudno, Yevgeny; Birnbaum, Michael E; Kleiner, Ralph E; Liu, David R. "An in vitro translation, selection and amplification system for peptide nucleic acids". Nature Chemical Biology. 6(2):148-155. doi:10.1038 / nchembio.280.PMC 2808706.PMID 20081830).
[0258] Target nucleic acid molecule
[0259] As used herein, when a nucleic acid molecule is to be detected, the "target nucleic acid molecule" refers to a polynucleotide molecule extracted from a biological sample (sample to be detected) or an amplified product, transcription product, or reverse transcription product thereof. When a non-nucleic acid molecule is to be detected, the "target nucleic acid molecule" is a pre-designed nucleic acid sequence. The biological sample is any solid or fluid sample obtained, excreted, or secreted from any organism, including but not limited to single-cell organisms, such as bacteria, yeast, protozoa, and amoeba, multicellular organisms (such as plants or animals, including samples from healthy or apparently healthy human subjects or human patients affected by a condition or disease to be diagnosed or investigated, such as infection by pathogenic microorganisms such as pathogenic bacteria or viruses). For example, a biological sample can be a biological fluid obtained from, for example, blood, plasma, serum, urine, feces, sputum, mucus, lymph, synovial fluid, bile, ascites, pleural effusion, seroma, saliva, cerebrospinal fluid, aqueous or vitreous humor, or any body secretion, exudate, exudate (e.g., fluid obtained from an abscess or any other infection or inflammation site) or a fluid obtained from a joint (e.g., a normal joint or a joint affected by a disease, such as rheumatoid arthritis, osteoarthritis, gout, or septic arthritis), or a swab of a skin or mucosal surface. A sample can also be a sample obtained from any organ or tissue (including a biopsy or autopsy specimen, such as a tumor biopsy) or a culture medium that can contain cells (primary cells or cultured cells) or conditioned by any cell, tissue, or organ. Exemplary samples include, but are not limited to, cells, cell lysates, blood smears, cytocentrifuge preparations, cytology smears, body fluids (e.g., blood, plasma, serum, saliva, sputum, urine, bronchoalveolar lavage, semen, etc.), tissue biopsies (e.g., tumor biopsies), fine needle aspirates, and / or tissue sections (e.g., cryostat tissue sections and / or paraffin-embedded tissue sections).
[0260] In other embodiments, the biological sample can be plant cells, callus, tissue or organ (such as roots, stems, leaves, flowers, seeds, fruits), etc.
[0261] In the present invention, the target nucleic acid molecule also includes a DNA molecule or RNA molecule formed by reverse transcription of RNA. Furthermore, the target nucleic acid molecule can be amplified by techniques known in the art. The amplification technique is an isothermal amplification technique and a non-isothermal amplification technique. Isothermal amplification can be NASBA (nucleic acid sequence-dependent amplification), RPA (recombinase polymerase amplification), LAMP (loop-mediated isothermal amplification), SDA (strand displacement amplification), HDA (helicase-dependent amplification), NEAR (nickase amplification reaction), bDNA (branched DNA amplification), TMA (transcription-mediated amplification), SPIA (single primer isothermal amplification), SMAP (smart amplification method), SMAP2 (smart amplification method version 2), CPA (cross primer amplification), MDA (multiple displacement amplification), cHDA (helicase-dependent Circular amplification), SMART (signal-mediated amplification technology of RNA, 3SR (self-directed sequence replication system), GEAR (genomic exponential amplification reaction), IMDA (isothermal multiple displacement amplification), ERA (enzymatic recombinase isothermal amplification), TAS (transcription-dependent amplification system). In certain exemplary embodiments, non-isothermal amplification methods can be used, including but not limited to PCR, MDA (multiple displacement amplification), RCA (rolling circle amplification), LCR (ligase chain reaction), or RAM (derivative amplification method). Furthermore, the detection method of the present invention further includes a step of amplifying the target nucleic acid molecule; the detection system further includes a reagent for amplifying the target nucleic acid molecule. The amplification reagent includes one or more of the following groups: DNA polymerase, chain displacement enzyme, helicase, recombinase, single-stranded binding protein, etc.
[0262] Detection system
[0263] This embodiment provides a detection system for detecting target nucleic acid molecules, comprising:
[0264] Nucleic acid detection compositions No. 1 to N, comprising corresponding Cas proteins No. 1 to N, corresponding guide RNAs No. 1 to N, corresponding Cas protein trans-cleavage reporter molecules No. 1 to N, and corresponding oligonucleotides No. 1 to N or oligonucleotide analogs; wherein the Cas protein is a V-type Cas protein; the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-1, the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-1 is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-2, and so on. The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of this number is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. 1 of this number, except when N=1; the guide RNAs No. 1 to N comprise direct repeats (Direct repeats) capable of binding to the corresponding Cas proteins No. 1 to N. Repeat, DR) sequence and a guide sequence capable of targeting the corresponding target sequences 1 to N; the 1st to Nth Cas protein trans-cleavage reporter molecules include the corresponding 1st to Nth single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules, and the 1st to Nth single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules do not hybridize with the guide sequence of the guide RNA in the system; and the 1st to Nth oligonucleotides or oligonucleotide analogs can be complementary to the corresponding 1st to Nth Cas protein trans-cleavage reporter molecules to form 1st to Nth blocked Cas protein trans-cleavage reporter molecules, and the trans-cleavage activity temperature of the 1st to Nth Cas proteins matches the melting temperature of the corresponding 1st to Nth blocked Cas protein trans-cleavage reporter molecules; wherein N is a positive integer ≥1, preferably, N is 1-20, more preferably, N is 1-15, and more preferably, N=1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11;
[0265] and / or
[0266] Nucleic acid detection compositions No. 1' to N', comprising corresponding Cas proteins No. 1' to N', corresponding guide RNAs No. 1' to N', corresponding Cas protein trans-cleavage reporters No. 1' to N', and corresponding oligonucleotides or oligonucleotide analogs No. 1' to N'; wherein the Cas protein is a type VI Cas protein; and the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N' is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-1. The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-1 is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-2. Similarly, the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of this number is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of the previous number, except that N'=1'; the guide RNA No. 1'-N' includes a direct repeat (Direct repeat) capable of binding to the corresponding Cas protein No. 1' to N' Repeat, DR) sequence and a guide sequence capable of targeting the corresponding 1' to N' target sequence; the 1' to N' Cas protein trans-cleavage reporter molecule includes the corresponding 1' to N' single-stranded nucleic acid molecule or single-stranded nucleic acid analog molecule, and the 1' to N' single-stranded nucleic acid molecule or single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system; and the 1' to N' oligonucleotide or oligonucleotide analog can be with the corresponding 1' to N' Cas protein The trans-cleavage reporter molecules are complementary to each other to form trans-cleavage reporter molecules of the blocked Cas proteins No. 1' to N', and the trans-cleavage activity temperature of the Cas proteins No. 1' to N' matches the melting temperature of the corresponding trans-cleavage reporter molecules of the blocked Cas proteins No. 1' to N'; wherein N' is a positive integer ≥1', preferably, N' is 1'-20', more preferably, N' is 1'-15', and more preferably, N'=1', 2', 3', 4', 5', 6', 7', 8', 9', 10' or 11'.
[0267] In another preferred example, the oligonucleotides No. 1 to N or oligonucleotide analogs are complementary to the corresponding single-stranded nucleic acid molecules No. 1 to N or single-stranded nucleic acid analog molecules of the corresponding Cas protein trans-cleavage reporter molecules No. 1 to N to form closed Cas protein trans-cleavage reporter molecules.
[0268] In another preferred example, the 1' to N' oligonucleotides or oligonucleotide analogs are complementary to the corresponding 1' to N' single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules of the corresponding 1' to N' Cas protein trans-cleavage reporter molecules to form closed Cas protein trans-cleavage reporter molecules.
[0269] In another preferred embodiment, the detection system for detecting target nucleic acid molecules further comprises:
[0270] a) an Mth nucleic acid detection composition, wherein the Mth nucleic acid detection composition comprises:
[0271] The Mth Cas protein, wherein the Mth Cas protein is a V-type Cas protein, preferably a VA-type Cas protein, more preferably Cas12a;
[0272] an Mth guide RNA, wherein the Mth guide RNA comprises a direct repeat (DR) sequence capable of binding to the Mth Cas protein and a guide sequence capable of targeting the Mth target sequence; and
[0273] The Mth Cas protein trans-cleaves the reporter molecule, wherein the Mth Cas protein trans-cleaves the reporter molecule including the Mth single-stranded nucleic acid molecule or the Mth single-stranded nucleic acid analog molecule, and the Mth single-stranded nucleic acid molecule or the Mth single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system;
[0274] and / or
[0275] The M'th Cas protein, wherein the M'th Cas protein is a type VI Cas protein, preferably a type VI-A Cas protein, more preferably Cas13a;
[0276] an M'th guide RNA, wherein the M'th guide RNA comprises a direct repeat (DR) sequence capable of binding to the M'th Cas protein and a guide sequence capable of targeting the M'th target sequence; and
[0277] The M'Cas protein trans-cleaves the reporter molecule, wherein the M'Cas protein trans-cleaves the reporter molecule, comprising the M' single-stranded nucleic acid molecule or the M' single-stranded nucleic acid analog molecule, wherein the M' single-stranded nucleic acid molecule or the M' single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system;
[0278] The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. 1 to No. N is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. M;
[0279] The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection compositions No. 1' to N' is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. M'.
[0280] More specifically, this embodiment provides a multiplex detection system for detecting target nucleic acid molecules, comprising:
[0281] a) a first nucleic acid detection composition, comprising a first V-type Cas protein (such as a VA-type Cas protein), a first guide RNA, and a first Cas protein trans-cleavage reporter molecule, wherein the first guide RNA comprises a direct repeat (DR) sequence capable of binding to the first V-type Cas protein and a guide sequence capable of targeting a first target sequence, and the first Cas protein trans-cleavage reporter molecule comprises a first single-stranded nucleic acid molecule or a single-stranded nucleic acid analog molecule that does not hybridize with the guide sequence of the guide RNA in the system;
[0282] b) a second nucleic acid detection composition, the second nucleic acid detection composition comprising a second V-type Cas protein (such as a VB-type Cas protein), a second guide RNA, a second Cas protein trans-cleavage reporter molecule, and a complementary oligonucleotide (oligo) or oligonucleotide analog of the second Cas protein trans-cleavage reporter molecule, the second guide RNA comprising a direct repeat (DR) sequence capable of binding to a second Cas protein and a guide sequence capable of targeting a second target sequence, the second Cas protein trans-cleavage reporter molecule having a second single-stranded nucleic acid molecule or a single-stranded nucleic acid analog molecule that does not hybridize with the guide sequence of the guide RNA in the system; the trans-cleavage activity temperature or inactivation temperature of the second V-type Cas protein is higher than the trans-cleavage activity temperature or inactivation temperature of the first V-type Cas protein; the second single-stranded nucleic acid molecule or the second single-stranded nucleic acid analog molecule of the second Cas protein trans-cleavage reporter molecule is complementary to the oligonucleotide or oligonucleotide analog to form a second blocked Cas protein trans-cleavage reporter molecule; the melting temperature of the second blocked Cas protein trans-cleavage reporter molecule matches the trans-cleavage activity temperature of the second V-type Cas protein.
[0283] c) an optional third nucleic acid detection composition, comprising a third type VI Cas protein, a third guide RNA, and a third Cas protein trans-cleavage reporter molecule, wherein the third guide RNA comprises a direct repeat (DR) sequence capable of binding to a third type VI Cas protein and a guide sequence capable of targeting a third target sequence, and the third Cas protein trans-cleavage reporter molecule comprises a third single-stranded nucleic acid molecule or a single-stranded nucleic acid analog molecule that does not hybridize with the guide sequence of the RNA in the system;
[0284] d) an optional fourth nucleic acid detection composition, the fourth nucleic acid detection composition comprising a fourth type VI Cas protein, a fourth guide RNA, a fourth Cas protein trans-cleavage reporter molecule, a fourth oligonucleotide or oligonucleotide analogue, the fourth guide RNA comprising a direct repeat (DR) sequence capable of binding to a fourth type VI Cas protein and a guide sequence capable of targeting a fourth target sequence, the fourth Cas protein trans-cleavage reporter molecule having a fourth single-stranded nucleic acid molecule or a single-stranded nucleic acid analogue molecule that does not hybridize with the guide sequence in the system, the fourth oligonucleotide or oligonucleotide analogue can be complementary to the fourth single-stranded nucleic acid molecule or the fourth single-stranded nucleic acid analogue molecule of the fourth Cas protein trans-cleavage reporter molecule to form a fourth closed Cas protein trans-cleavage reporter molecule; the trans-cleavage activity temperature or inactivation temperature of the fourth type VI Cas protein is higher than the trans-cleavage activity temperature or inactivation temperature of the third type VI Cas protein; the melting temperature of the fourth closed Cas protein trans-cleavage reporter molecule matches the trans-cleavage activity temperature of the fourth type VI Cas protein.
[0285] In a preferred embodiment, the fourth type VI Cas protein is a heat-resistant type VI Cas protein, and the third type VI Cas protein is a type VI Cas protein other than the heat-resistant type VI Cas protein. Preferably, the heat-resistant type VI Cas protein includes TccCas13a (from article PMID: 35763567PMCID: PMC9282225 DOI:10.1073 / pnas.2118260119), the third type VI Cas protein includes LwaCas13a, LbaCas13a, LshCas13a, PprCas13a, EreCas13a, LneCa13a, CamCas13a, RcaCas13a, HheCas13a, LbuCas13a, LseCas13a, LbmCas13a, LbnCas13a, RcsCas13a, RcrCas13a, RcdCas13a, CgCas13a, Cg2Cas13a, LweCas13a, LbfCas13a, Lba4Cas13a, Lba9Cas13a, LneCas13a, HheCas13a, RcaCas13a, BzCas13b, PbCas13b, PspCas13b, RanCas13b, PguCas13b, PsmCas13b, CcaCas13b, AspCas13b, PauCas13b, Pin2Cas13b, Pin3Cas13b, RspCas13d, RfxCas13d, EsCas13d, AdmCas13d.
[0286] The multiplex detection system based on type V Cas proteins developed by the present invention is of great significance for expanding CRISPR multiplex detection methods. At the same time, based on the multiplex detection system based on type V Cas proteins, the present invention is also compatible with the detection system of type VI Cas proteins, further combining the multiplex detection system of type V Cas and type VI Cas proteins.
[0287] Based on the principle of the present invention, not only double and triple detection can be achieved, but also quadruple, quintuple, sextuple, septuple, octuple, ninefold, decaplex and other multiple detections can be achieved. As long as the trans-cleavage activity temperature of the Cas protein matches the melting temperature of the closed Cas protein trans-cleavage reporter molecule formed by the Cas protein trans-cleavage reporter molecule and the oligonucleotide or oligonucleotide analog; and does not conflict with the trans-cleavage activity temperature or inactivation temperature of other Cas proteins (for example, at this temperature, the Cas protein corresponding to the closed Cas protein trans-cleavage reporter molecule with a relatively lower melting temperature has been inactivated). For example, to achieve five-fold detection, a set of nucleic acid detection compositions can be added, including:
[0288] A fifth V-type or VI-type Cas protein, wherein the trans-cleavage activity temperature or inactivation temperature of the fifth V-type Cas protein is different from the trans-cleavage activity temperature or inactivation temperature of the first V-type Cas protein or the second V-type Cas protein, or the trans-cleavage activity temperature or inactivation temperature of the fifth VI-type Cas protein is different from the trans-cleavage activity temperature or inactivation temperature of the third VI-type Cas protein or the fourth VI-type Cas protein;
[0289] a fifth guide RNA comprising a direct repeat (DR) sequence capable of binding to a fifth type V or type VI Cas protein and a guide sequence capable of targeting a second target sequence,
[0290] a fifth Cas protein trans-cleaving reporter molecule, wherein the fifth Cas protein trans-cleaving reporter molecule has a fifth single-stranded nucleic acid molecule or a single-stranded nucleic acid analog molecule that does not hybridize with the guide sequence of the guide RNA in the system;
[0291] A fifth oligonucleotide (oligo) or oligonucleotide analog, the fifth oligonucleotide (oligo) or oligonucleotide analog and the fifth Cas protein trans-cleavage reporter molecule are complementary; the melting temperature of the fifth closed Cas protein trans-cleavage reporter molecule formed by the fifth Cas protein trans-cleavage reporter molecule and the oligonucleotide or oligonucleotide analog matches the trans-cleavage activity temperature of the fifth V-type or VI-type Cas protein.
[0292] By analogy, sixfold, sevenfold, eightfold, ninefold, tenfold and other multiple detections can be achieved.
[0293] The method for detecting a target nucleic acid molecule in this embodiment comprises subjecting the sample to be detected to the following reaction:
[0294] i) contacting the sample to be tested with the detection system for detecting target nucleic acid molecules according to the fourth aspect of the present invention, and reacting at a first detection temperature;
[0295] ii) detecting a detectable signal generated by the trans-cleavage reporter molecule No. 1 and / or the trans-cleavage reporter molecule No. 1' by the Cas protein in the detection system, thereby detecting the target sequence No. 1 corresponding to the trans-cleavage reporter molecule No. 1 and / or the target sequence No. 1' corresponding to the trans-cleavage reporter molecule No. 1' by the Cas protein;
[0296] iii) gradually increasing the temperature, gradually allowing the next closed Cas protein trans-cleavage reporter molecule to release the corresponding Cas protein trans-cleavage reporter molecule and inactivating the current Cas protein, and detecting the detectable signal generated by the next Cas protein trans-cleavage reporter molecule (for example, allowing the closed Cas protein trans-cleavage reporter molecule in the nucleic acid detection composition No. N to release the corresponding Cas protein trans-cleavage reporter molecule and inactivate the Cas protein No. N-1, allowing the closed Cas protein trans-cleavage reporter molecule in the nucleic acid detection composition No. N-1 to release the corresponding Cas protein trans-cleavage reporter molecule and inactivate the Cas protein No. N-2, and so on, except when N=1), thereby detecting the corresponding target sequence.
[0297] In another preferred example, the method for detecting the target nucleic acid molecule further includes performing a reaction at the Mth detection temperature, detecting a detectable signal generated by the Mth Cas protein trans-cutting reporter molecule and / or the M'Cas protein trans-cutting reporter molecule in the detection system, thereby detecting the Mth target sequence corresponding to the Mth Cas protein trans-cutting reporter molecule and / or the M' target sequence corresponding to the M'Cas protein trans-cutting reporter molecule; the obtained Mth detection temperature is lower than the first detection temperature, and the Mth Cas protein and / or the M'Cas protein is inactivated at the first temperature.
[0298] In the present invention, the detection system of the present invention is a one-tube multiplex detection system.
[0299] Detection method
[0300] This specific embodiment discloses a method for detecting target nucleic acid molecules, particularly a method for detecting one or more target nucleic acid molecules using the multiple detection system for detecting target nucleic acid molecules described herein (i.e., a system comprising a first nucleic acid detection composition, a second nucleic acid detection composition, and an optional third detection composition).
[0301] This specific embodiment provides a method for detecting target nucleic acid molecules, especially using VB type Cas protein (such as Cas12b), V type Cas protein (such as VA type Cas protein, Cas12a) in addition to VB type Cas protein, and optional VI type Cas protein to detect target DNA or simultaneously detect target DNA and RNA molecules. Once the cis-cutting substrate (single-stranded or double-stranded), guide RNA and Cas protein form a ternary complex, the complex will non-specifically cut the trans-cutting reporter molecule (trans-cutting reporter molecule, or nucleic acid probe, nucleic acid probe includes single-stranded DNA molecule or single-stranded RNA molecule, depending on the corresponding Cas protein, preferably, the nucleic acid probe is a thio-modified nucleic acid probe) in the system, and the target nucleic acid molecule, such as target DNA, is determined by the detection signal. Whether the target RNA molecule exists.
[0302] The principle of Cas12a / Cas12b dual CRISPR detection is that at 37°C, Cas12a (such as LbCas12a) can normally exercise trans-cutting activity. When the reaction system or detection system is added with an oligo complementary to the probe used for detecting the fluorescent channel of Cas12b (such as AapCas12b) (i.e., the complementary oligonucleotide (oligo) of the Cas12b trans-cutting reporter molecule), the two form double-stranded DNA, thereby blocking the trans-cutting activity of the probe used for detecting the fluorescent channel of Cas12a (such as LbCas12a) to Cas12b (such as AapCas12b). At this time, Cas12a (such as LbCas12a) can only cut the probe used for its fluorescent channel. When the detection temperature rises to 60°C, Cas12a (such as LbCas12a) is inactivated and denatured, and Cas12b (such as AapCas12b) is a high-temperature resistant protein, and its protein activity is normal at its temperature. Under high temperature conditions of 60°C, the probe used in the Cas12b (such as AapCas12b) detection channel is melted with the complementary oligo to form a single-stranded probe, which can be used as the probe required for trans-cleavage by Cas12b (such as AapCas12b). Therefore, at 37°C, the first target sequence of Cas12a can be detected, and at 60°C, the second target sequence of Cas12b can be detected.
[0303] The principle of Cas12a / Cas12b / Cas13 triple CRISPR detection is to use the different types of trans-cleavage probes of the Cas13 detection system and the Cas12 system. The trans-cleavage probe used by the Cas13 detection system is an RNA probe, while the trans-cleavage probe used by the Cas12 detection system is a DNA probe. Therefore, the Cas13 detection system added to the Cas12a / Cas12b dual detection system will not interfere with the detection of the Cas12a / Cas12b dual detection system. In addition, the added Cas13 detection system is compatible with the Cas12a / Cas12b dual detection system, thus forming a Cas12a / Cas12b / Cas13 triple CRISPR detection system.
[0304] A typical nucleic acid probe is a single-stranded DNA or single-stranded RNA with a luminescent group and a quencher group attached to both ends, so that once the probe is cut, the luminescent group can emit light.
[0305] In this specific embodiment, by detecting fluorescence, it can be known whether the system to be detected contains target nucleic acid molecules such as target DNA and target RNA molecules.
[0306] In this embodiment, suitable Cas proteins are V-type Cas proteins and VI-type Cas proteins with trans-cleavage activity, preferably Cas12a, Cas12b, Cas13, and preferably the Cas12a is preferably FnCas12a, LbCas12a, ErCas12a, Evcas12a, Lb5Cas12a, HkCas12a, OsCas12a, TsCas12a, BbCas12a, BoCas12a, Lb4Cas12a, CeCas12a, PrC as12a, CsbCas12a, BhCas12a, SsCas12a, Lb3Cas12a, BpCas12a, PdCas12a, BfCas12a, PcCas12a, cMtCas12a, PeCas12a, LiCas12a, Lb2Cas12a, PmCas12a, MbCas12a, EeCas12a, CsbCas12a, ArCas12a, BsCas12a, AbCas12a, AsCas12a, or a combination thereof. Preferably, the Cas12b is preferably AacCas12b, AaCas12b, BthCas12b, AapCas12b, AkCas12b, AmCas12b, Bs3Cas12b, LsCas12b, BrCas12b (from Brevibacillus sp.SYP-B805, from the article PMID: 31926228 DOI: 10.1016 / j.ijbiomac.2020.01.079), and preferably Cas13 is preferably Cas13a, Cas13b, Cas13c, Cas13d, Cas13e, Cas13f, Cas13x, Cas13y or a combination thereof.
[0307] The detection method of this embodiment can detect nucleic acid molecules of different species, such as nucleic acid molecules of mammals, plants, microorganisms, and viruses. The method of this embodiment is particularly suitable for detecting pathogenic microorganisms, gene mutations, or specific target DNA, or target DNA and RNA.
[0308] The method of this embodiment can be used to quickly detect whether a sample contains one or more target nucleic acid molecules. In addition, by combining it with amplification techniques (such as TMA, NSBA, SMART, RCA, RT-PCR, RT-LAMP, RT-RPA, etc.), the sensitivity of the detection method can be greatly improved. The components used in various amplification techniques in this application, such as:
[0309] NTP, buffer, and Mg required for RNA amplification 2+etc., as well as RNase H required when reverse transcriptase has no function in digesting single-stranded RNA;
[0310] dNTPs, buffer, and Mg required for DNA amplification 2+ wait;
[0311] These contents are common knowledge in this field, so they are not described in detail in this application.
[0312] The main advantages of this embodiment include:
[0313] (1) The present invention utilizes for the first time the different optimal reaction activity temperatures or inactivation temperatures of VB-type Cas proteins (such as Cas12b) and V-type Cas proteins other than VB-type Cas proteins (such as VA-type Cas proteins, such as Cas12a). Under different temperature conditions, the complementary binding states of oligo and Cas trans-cleavage probes are different, thereby shielding the Cas trans-cleavage activity. When under low temperature conditions, oligo and Cas trans-cleavage probes complement each other and can prevent trans-cleavage by Cas protein. When under high temperature conditions, the Cas trans-cleavage probe blocked by oligo will reopen to form a single chain and can be trans-cleaved by the Cas enzyme. In addition, under high temperature conditions, V-type Cas proteins other than VB-type Cas proteins (such as VA-type Cas proteins, such as Cas12a) are inactivated. At this time, only the high-temperature-resistant VB-type Cas protein (such as Cas12b) can function, thereby realizing dual detection of two V-type Cas proteins in the same reaction system or detection system.
[0314] (2) The present invention utilizes the difference between Cas12a and Cas12b reaction temperatures for the first time, utilizes oligo to seal the probe of Cas12b detection channel, avoids the influence of Cas12a trans-cutting activity on Cas12b detection channel probe, so as to achieve Cas12a / Cas12b dual detection. The present invention utilizes oligo to seal the probe of Cas12b detection channel under Cas12a low temperature reaction conditions, avoids Cas12a trans-cutting the probe of Cas12b detection channel, and Cas12a trans-cutting activity can only act on the probe of Cas12a detection channel. When under Cas12b high temperature reaction conditions, Cas12a inactivates and denatures, and at high temperature conditions, the probe of Cas12b detection channel sealed by oligo is reopened to form a single chain, which can be trans-cut by Cas12b. On the basis of Cas12a / Cas12b dual detection system, Cas13 detection system is added again, so as to achieve triple detection of Cas12a, Cas12b and Cas13 in the same reaction system or detection system.
[0315] (3) The present invention has developed a multiplex detection system for detecting target nucleic acid molecules for the first time. The present invention combines (a) VB type Cas protein, corresponding guide RNA, Cas protein trans-cutting reporter molecule, oligonucleotide or oligonucleotide analogue, and V type Cas protein other than VB type Cas protein and corresponding guide RNA, Cas protein trans-cutting reporter molecule and (b) VI type Cas protein, corresponding guide RNA, Cas protein trans-cutting reporter molecule for the first time, for detecting one or more different target nucleic acid molecules in a reaction system, and can obtain very high detection sensitivity and specificity, and the detection system of the present invention is based on the multiple detection system based on Cas12 protein, and can also be compatible with the detection system of Cas13 protein, and further combined into Cas12 and Cas13 protein multiple detection system.
[0316] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are intended to illustrate the present invention only and are not intended to limit the scope of the present invention. The experimental methods in the following examples, for which specific conditions are not specified, are generally performed under conventional conditions, such as those described in Sambrook et al., Molecular Cloning: A Laboratory Manual (New York: Cold Spring Harbor Laboratory Press, 1989), or according to the conditions recommended by the manufacturer. Unless otherwise stated, percentages and parts are by weight.
[0317] Unless otherwise specified, the materials and reagents used in the examples of this embodiment are all commercially available products. Various Cas proteins and TOLO buffer were purchased from Anhui Tolo Biotechnology Co., Ltd.
[0318] Example 1: Cas12a / Cas12b dual CRISPR detection system example 1
[0319] 1.1 Cas12a / Cas12b dual probe sequence design
[0320] The principle of Cas12a / Cas12b dual CRISPR detection is that at 37°C, LbCas12a can normally perform trans-cleavage activity. When an oligo complementary to the probe used in the AapCas12b detection fluorescent channel is added to the reaction system, the two form double-stranded DNA, thereby blocking LbCas12a's trans-cleavage activity on the probe used in the AapCas12b detection fluorescent channel. At this time, LbCas12a can only cut the probe used in its fluorescent channel. When the detection temperature rises to 60°C, LbCas12a is inactivated and denatured. AapCas12b is a high-temperature resistant protein and its protein activity is normal at this temperature. Under high temperature conditions of 60°C, the probe used in the AapCas12b detection channel is melted with the complementary oligo to form a single-stranded probe, which can be used as the probe required for AapCas12b trans-cleavage. It should be noted that the LbCas12a protein is used to detect the internal reference, and the AapCas12b protein is used to detect the target.
[0321] In this example, the probe and complementary oligo sequences designed and synthesized are as follows:
[0322] Table 1 Probe sequences for the Cas12a / Cas12b dual detection system
[0323] Note: FAM and ROX are different fluorescent groups. iROXdT indicates that ROX is modified at the T base in the middle of the sequence. BHQ1 and BHQ2 are quenching groups. iBHQ2dT indicates that BHQ2 is modified at the T base in the middle of the sequence.
[0324] See Figure 15. The fluorescent group and quencher group of Cas12b-Reporter1 are modified in the middle position of the reporter sequence. The main purpose is to prevent Cas12b-Reporter1 from forming a double strand with CS-Cas12b-Oligo1. Due to the presence of DNA respiration, the Cas12a enzyme can cut Cas12b-Reporter1. When the fluorescent group and the quencher group are modified in the middle position of the reporter sequence, CS-Cas12b-Oligo1 can completely block Cas12b-Reporter1, prevent the cutting of Cas12a enzyme, and modify the sequence end complementary to the CS-Cas12b-Oligo1 and Cas12b-Reporter1 fluorescent group modifications with the quencher group, further reducing the background fluorescence signal of the reaction system.
[0325] 1.2 Synthesis of guide RNA
[0326] LbCas12a protein was used to detect the RP internal reference, and AapCas12b protein was used to detect the COVID-19 N gene.
[0327] RP internal reference crRNA sequence (RP-crRNA):
[0328] COVID-19 N gene sgRNA sequence (COVID-19 N-sgRNA):
[0329] RP-crRNA and COVID-19 N-sgRNA were synthesized by Sangon Biotech (Shanghai) Co., Ltd.
[0330] 1.3 LAMP amplification detection target
[0331] The target to be detected can be amplified using PCR or other nucleic acid amplification methods. In this embodiment, the LAMP isothermal amplification method is used.
[0332] (1) Extraction of target nucleic acid: Use Tiangen Bio's viral RNA extraction kit (DP315-R) to extract nucleic acid from Jingliang COVID-19 pseudovirus whole genome quality control product II (including human internal reference).
[0333] (2) LAMP amplification reaction: The total volume of the LAMP amplification reaction was 25 μL, and the COVID-19 N gene and the internal reference RP gene were amplified respectively (primer sequences are shown in Table 2). The total amount of LAMP primers was F3 and B3: 0.2 μM, FIP and BIP: 1.6 μM, LF and LB: 0.4 μM, of which the COVID-19 N gene primers accounted for 80% and the internal reference RP gene accounted for 20%. The kit used for the LAMP amplification reaction was Bst 2.0 DNA Polymerase (NEB) and RTx Reverse Transcriptase (NEB). LAMP reaction program was 63°C for 35 min.
[0334] Table 2 Primer sequences
[0335] 1.4 Cas12a / Cas12b dual detection system
[0336] The volume of the Cas12a / Cas12b dual detection system is 20 μL, as shown below:
[0337] Table 2' Cas12a / Cas12b dual detection system components
[0338] After the Cas12a / Cas12b dual detection system was prepared, the detection was performed on a fluorescent quantitative PCR instrument at 37°C for 5 min and 60°C for 5 min, and the FAM and ROX channel signals were collected every 15 s.
[0339] 1.5 Test results
[0340] Figure 1 is a graph showing the fluorescence channel curve of LbCas12a detecting the RP internal reference FAM. Figure 2 is a graph showing the fluorescence channel curve of AapCas12b detecting the COVID-19 N gene ROX. Figure 3 is a combination of Figures 1 and 2.
[0341] The results showed that the Cas12a / Cas12b dual CRISPR detection system based on LAMP amplification can normally complete the dual detection of internal reference genes and target genes.
[0342] Example 2: Cas12a / Cas12b dual CRISPR detection system example 2
[0343] 2.1 Cas12a / Cas12b dual probe sequence design
[0344] The probe design of this embodiment 2 is different from that of embodiment 1. The Cas12b detection channel probe is modified with phosphorothioate (PS). In this embodiment, the probe and complementary oligo designed and synthesized have the following sequences:
[0345] Table 3 Cas12a / Cas12b dual detection system probe sequences
[0346] Note: FAM and ROX are different fluorescent groups; BHQ1 and BHQ2 are quenching groups;
[0347] * indicates phosphorothioate modification (PS).
[0348] See Figure 16. The fluorescent group and quencher group of Cas12b-Reporter2 are modified at both ends of the reporter sequence, and the partial sequence near both ends is modified with thio, and its main purpose is to prevent Cas12b-Reporter2 from forming a double chain with CS-Cas12b-Oligo2. Due to the presence of DNA respiration, Cas12a enzyme is able to cut Cas12b-Reporter2. When the fluorescent group and quencher group are modified at both ends of the reporter sequence, and the partial sequence near both ends is modified with thio, CS-Cas12b-Oligo2 can completely block Cas12b-Reporter2, prevent the cutting of Cas12a enzyme, and the complementary sequence ends of CS-Cas12b-Oligo2 and Cas12b-Reporter2 fluorescent group are modified with quencher group, further reducing the background fluorescence signal of the reaction system.
[0349] 2.2 Synthesis of guide RNA
[0350] LbCas12a protein was used to detect the RP internal reference, and AapCas12b protein was used to detect the COVID-19 N gene.
[0351] RP internal reference crRNA sequence (RP-crRNA2):
[0352] COVID-19 N gene sgRNA sequence (COVID-19 N-sgRNA2):
[0353] GUCUAGAGGACAGAAUUUUUCAACGGGUGUGCCAAUGGCCACUUUCCAGGUGGCAAAGCCCGUUGAGCUUCUCAAAUCUGAGAAGUGGCACUCCUGCUAGAAUGGCUGGCA (SEQ ID NO. 16). RP-crRNA2 and COVID-19 N-sgRNA2 were synthesized by Sangon Biotech (Shanghai) Co., Ltd.
[0354] 2.3 PCR amplification and detection of targets
[0355] PCR or other nucleic acid amplification methods can be used to amplify the target to be detected. In this embodiment, PCR amplification method is used.
[0356] (1) Extraction of target nucleic acid: Use Tiangen Bio's viral RNA extraction kit (DP315-R) to extract nucleic acid from Jingliang COVID-19 pseudovirus whole genome quality control product II (including human internal reference).
[0357] (2) PCR amplification reaction: The total volume of the PCR amplification reaction was 25 μL, and the COVID-19 N gene and the internal reference RP gene were amplified respectively (primer sequences are shown in Table 4). The kit used for the PCR amplification reaction was Platinum TM Taq DNA Polymerase (ThermoFisher) and SuperScript TM The PCR program was 55°C for 15 min, 94°C for 3 min, and then 40 cycles of 94°C for 15 s and 55°C for 45 s.
[0358] Table 4 Primer sequences
[0359] 2.4 Cas12a / Cas12b dual detection system
[0360] The volume of the Cas12a / Cas12b dual detection system is 20 μL, as shown below:
[0361] Table 4' Cas12a / Cas12b dual detection system components
[0362] After the Cas12a / Cas12b dual detection system was prepared, the detection was performed on a fluorescent quantitative PCR instrument at 37°C for 5 min and 60°C for 5 min, and the FAM and ROX channel signals were collected every 15 s.
[0363] 2.5 Test results
[0364] Figure 4 is a graph showing the fluorescence channel of the RP internal reference FAM detected by LbCas12a. Figure 5 is a graph showing the fluorescence channel of the COVID-19 N gene ROX detected by AapCas12b. Figure 6 shows a combination of Figures 4 and 5.
[0365] The results showed that the Cas12a / Cas12b dual CRISPR detection system based on PCR amplification can normally complete the dual detection of internal reference genes and target genes.
[0366] Example 3: Example of Cas12a / Cas12b / Cas13 multiplex CRISPR detection system
[0367] 3.1 Cas12a / Cas12b / Cas13 multiplex probe sequence design
[0368] In this embodiment, Cas13 was added to the Cas12a / Cas12b dual CRISPR detection system to form a Cas12a / Cas12b / Cas13 multiple CRISPR detection system. Cas13 recognizes RNA targets, and its trans-cleavage activity is RNA. In this embodiment, the probes and complementary oligos designed and synthesized have the following sequences:
[0369] Table 5 Cas12a / Cas12b / Cas13 multiplex detection system probe sequences
[0370] Note: FAM, VIC, and ROX are different fluorescent groups. iROXdT indicates that ROX is modified at the T base in the middle of the sequence. BHQ1 and BHQ2 are quenching groups. iBHQ2dT indicates that BHQ2 is modified at the T base in the middle of the sequence.
[0371] 3.2 Guide RNA Synthesis
[0372] LbCas12a protein was used to detect the RP internal reference, AapCas12b protein was used to detect the COVID-19 N gene, and LwaCas13a protein was used to detect the COVID-19 ORF1ab gene.
[0373] RP internal reference crRNA sequence (RP-crRNA2):
[0374] COVID-19 N gene sgRNA sequence (COVID-19 N-sgRNA2):
[0375] COVID-19 ORF1ab gene crRNA sequence (COVID-19 O-crRNA):
[0376] GAUUUAGACUACCCCAAAAACGAAGGGGACUAAAACTGGGTTCGCGGAGTTGATCACAACTACA. RP-crRNA2, COVID-19 N-sgRNA2, and COVID-19 O-crRNA were synthesized by Sangon Biotech (Shanghai) Co., Ltd.
[0377] 3.3 PCR amplification and detection of targets
[0378] PCR or other nucleic acid amplification methods can be used to amplify the target to be detected. In this embodiment, PCR amplification method is used.
[0379] (1) Extraction of target nucleic acid: Use Tiangen Bio's viral RNA extraction kit (DP315-R) to extract nucleic acid from Jingliang COVID-19 pseudovirus whole genome quality control product II (including human internal reference).
[0380] (2) PCR amplification reaction: The total volume of the PCR amplification reaction was 25 μL, and the COVID-19 N gene, ORF1ab gene and internal reference RP gene were amplified respectively (primer sequences are shown in Table 6). The kit used for the PCR amplification reaction was Platinum TM Taq DNA Polymerase (ThermoFisher) and SuperScript TM The PCR program was 55°C for 15 min, 94°C for 3 min, and then 40 cycles of 94°C for 15 s and 55°C for 45 s.
[0381] Table 6 Primer sequences
[0382] 3.4 Cas12a / Cas12b / Cas13 Multiplex Detection System
[0383] The volume of the Cas12a / Cas12b / Cas13 multiplex detection system is 20 μL, as shown below:
[0384] Table 6' Components of Cas12a / Cas12b / Cas13 multiplex detection system
[0385] After the Cas12a / Cas12b / Cas13 multiplex detection system was prepared, the detection was performed on a fluorescence quantitative PCR instrument at 37°C for 5 min and 60°C for 5 min, and the FAM, VIC, and ROX channel signals were collected every 15 s.
[0386] 3.5 Test results
[0387] Figure 7 is a graph showing the fluorescence channel of the RP internal reference FAM detected by LbCas12a. Figure 8 is a graph showing the fluorescence channel of the COVID-19 ORF1ab gene VIC detected by LwaCas13a. Figure 9 is a graph showing the fluorescence channel of the COVID-19 N gene ROX detected by AapCas12b. Figure 10 combines Figures 7, 8, and 9.
[0388] The results showed that the Cas12a / Cas12b / Cas13 multiplex CRISPR detection system based on PCR amplification can normally complete the multiplex detection of internal reference genes and target genes.
[0389] Example 4: Example of sensitivity test of Cas12a / Cas12b / Cas13 multiplex CRISPR detection system
[0390] The detection sensitivity of the system for detecting the COVID-19 virus (SARS-CoV-2) was tested according to the detection system of Example 3.
[0391] 4.1 Sensitivity detection
[0392] Jingliang COVID-19 pseudovirus whole genome quality control product II (including human internal reference) was diluted to 500 copies / mL using virus sample preservation solution, and then nucleic acid was extracted using Tiangen Bio's viral RNA extraction kit (DP315-R). The entire detection process was carried out according to Example 3, and the extracted nucleic acid was tested repeatedly 3 times.
[0393] 4.2 Test results
[0394] 500 copies / mL of Jingliang COVID-19 pseudovirus whole genome quality control product II (including human internal reference) was tested and detected after three repeated tests. Figure 11 is a graph of the FAM fluorescence channel of the RP internal reference detected by LbCas12a. Figure 12 is a graph of the VIC fluorescence channel of the COVID-19 ORF1ab gene detected by LwaCas13a. Figure 13 is a graph of the ROX fluorescence channel of the COVID-19 N gene detected by AapCas12b. Figure 14 is a combination of Figures 11, 12, and 13.
[0395] The results showed that the Cas12a / Cas12b / Cas13 multiplex CRISPR detection system based on PCR amplification was able to normally complete multiplex detection of internal reference genes and target genes. All target genes of the 500 copies / mL Jingliang COVID-19 pseudovirus whole genome quality control product II (including human internal reference) were detected, indicating that the system has very high detection sensitivity. In addition, this system is a CRISPR multiplex detection based on PCR amplification, which theoretically can also improve the specificity of the detection.
[0396] All documents mentioned in this application are incorporated herein by reference, just as if each document were incorporated herein by reference individually. It should also be understood that after reading the above teachings of the present invention, those skilled in the art may make various changes or modifications to the present invention, and that such equivalents also fall within the scope of the claims appended hereto.
Claims
1. Use of an oligonucleotide or an oligonucleotide analog, characterized in that: Used to block Cas protein trans-cleavage reporter molecules.
2. The use according to claim 1, characterized in that The oligonucleotide or oligonucleotide analog is modified with a quencher group.
3. A use of a hairpin-type or double-stranded nucleic acid or nucleic acid analog molecule, characterized in that: The hairpin-type or double-stranded nucleic acid or nucleic acid analog molecule comprises: A single-stranded nucleic acid molecule or a single-stranded nucleic acid analog molecule, wherein the single-stranded nucleic acid molecule or the single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA of the Cas protein; An oligonucleotide or an oligonucleotide analog, wherein the oligonucleotide or the oligonucleotide analog is complementary to the single-stranded nucleic acid molecule or the single-stranded nucleic acid analog molecule and blocks the single-stranded nucleic acid molecule or the single-stranded nucleic acid analog molecule; The single-stranded nucleic acid molecule or single-stranded nucleic acid analog molecule and the oligonucleotide or oligonucleotide analog form a double-stranded molecule or a hairpin molecule; The double-stranded nucleic acid molecule is used as a part of a Cas protein trans-cleavage reporter molecule, for a detection method utilizing the trans-cleavage activity of the Cas protein, or for preparing a composition for detecting the trans-cleavage activity of the Cas protein, or for preparing a product combination for detecting the trans-cleavage activity of the Cas protein, or for preparing a reagent for detecting the trans-cleavage activity of the Cas protein, or for preparing a nucleic acid detection kit utilizing the trans-cleavage activity of the Cas protein, or for preparing a system for detecting the trans-cleavage activity of the Cas protein.
4. A closed Cas protein trans-cleavage reporter molecule, characterized in that include: Cas protein trans-cleavage reporter molecules, Cas protein trans-cleavage reporter molecules include single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules, and the single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules do not hybridize with the guide sequence of the guide RNA of the Cas protein; An oligonucleotide or an oligonucleotide analogue, wherein the oligonucleotide or the oligonucleotide analogue is complementary to the single-stranded nucleic acid molecule or the single-stranded nucleic acid analogue molecule and blocks the single-stranded nucleic acid molecule or the single-stranded nucleic acid analogue molecule.
5. A detection system for detecting a target nucleic acid molecule, characterized in that: include: Nucleic acid detection compositions No. 1 to N, comprising corresponding Cas proteins No. 1 to N, corresponding guide RNAs No. 1 to N, corresponding Cas protein trans-cleavage reporter molecules No. 1 to N, and corresponding oligonucleotides or oligonucleotide analogs No. 1 to N; the Cas protein is a V-type Cas protein; the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-1 is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-2, and so on, the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of this number is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. 1 of this number, except when N=1; the guide RNAs No. 1 to N include direct repeats (Direct repeats) that can bind to the corresponding Cas proteins No. 1 to N. Repeat, DR) sequence and a guide sequence capable of targeting the corresponding 1st to Nth target sequences; the 1st to Nth Cas protein trans-cleavage reporter molecules include the corresponding 1st to Nth single-stranded nucleic acid molecules or single-stranded nucleic acid analog molecules, the 1st to Nth The single-stranded nucleic acid molecule or single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system; and the oligonucleotides 1 to N can be complementary to the corresponding Cas protein trans-cleavage reporter molecules 1 to N, and can form the Cas protein trans-cleavage reporter molecules 1 to N, and the trans-cleavage activity temperature of the Cas protein 1 to N matches the melting temperature of the corresponding Cas protein trans-cleavage reporter molecules 1 to N; wherein N is a positive integer ≥ 1, preferably, N is 1-20, more preferably, N is 1-15, and more preferably, N = 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11; and / or The nucleic acid detection composition No. 1' to N', wherein the nucleic acid detection composition No. 1' to N' comprises the corresponding Cas protein No. 1' to N', the corresponding guide RNA No. 1' to N', the corresponding Cas protein trans-cleavage reporter molecule No. 1' to N' and the corresponding oligonucleotide No. 1' to N' or oligonucleotide analog; the Cas protein is a type VI Cas protein; the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N' is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-1, and the The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-1 is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-2, and so on. The trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of this number is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of the previous number of this number, except when N'=1'; the guide RNA Nos. 1' to N' include direct repeats (Direct Repeat, DR) sequence and a guide sequence capable of targeting the corresponding target sequence No. 1' to N'; the Cas protein No. 1' to N' trans-cutting reporter molecule includes the corresponding single-stranded nucleic acid molecule No. 1' to N' or single-stranded nucleic acid analog molecule, and the single-stranded nucleic acid molecule No. 1' to N' or single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system; and the oligonucleotide No. 1' to N' or oligonucleotide analog can be trans-cut with the corresponding Cas protein No. 1' to N' The reporter molecules are complementary to each other to form trans-cutting reporter molecules of Cas proteins blocked from 1' to N', and the trans-cutting activity temperature of Cas proteins from 1' to N' matches the melting temperature of the corresponding trans-cutting reporter molecules of Cas proteins blocked from 1' to N'; wherein N' is a positive integer ≥ 1', preferably, N' is 1'-20', more preferably, N' is 1'-15', and more preferably, N'=1', 2', 3', 4', 5', 6', 7', 8', 9', 10' or 11'.
6. A multiplex detection system for detecting target nucleic acid molecules, characterized in that: include: a) a first nucleic acid detection composition, the first nucleic acid detection composition comprising: The first type V Cas protein; A first guide RNA, wherein the first guide RNA comprises a direct repeat (DR) sequence capable of binding to a first V-type Cas protein and a guide sequence capable of targeting a first target sequence; and A first Cas protein trans-cleaves a reporter molecule, wherein the first Cas protein trans-cleaves a reporter molecule comprising a first single-stranded nucleic acid molecule or a first single-stranded nucleic acid analog molecule, wherein the first single-stranded nucleic acid molecule or the first single-stranded nucleic acid analog molecule does not hybridize with a guide sequence of a guide RNA in the system; b) a second nucleic acid detection composition, the second nucleic acid detection composition comprising: a second V-type Cas protein, wherein the trans-cleavage activity temperature or inactivation temperature of the second V-type Cas protein is higher than the trans-cleavage activity temperature or inactivation temperature of the first V-type Cas protein; A second guide RNA, wherein the second guide RNA comprises a direct repeat (DR) sequence capable of binding to a second V-type Cas protein and a guide sequence capable of targeting a second target sequence; and A second Cas protein trans-cleaves the reporter molecule, wherein the second Cas protein trans-cleaves the reporter molecule comprises a second single-stranded nucleic acid molecule or a second single-stranded nucleic acid analog molecule, and the second single-stranded nucleic acid molecule or the second single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system; An oligonucleotide or an oligonucleotide analog, wherein the oligonucleotide or the oligonucleotide analog can be complementary to the second single-stranded nucleic acid molecule or the second single-stranded nucleic acid analog molecule of the second Cas protein trans-cleavage reporter molecule to form a second closed Cas protein trans-cleavage reporter molecule; The melting temperature of the second closed Cas protein trans-cleavage reporter molecule formed by the second Cas protein trans-cleavage reporter molecule and the oligonucleotide or oligonucleotide analog matches the trans-cleavage activity temperature of the second V-type Cas protein; The first V-type Cas protein is a V-type Cas protein other than the VB-type Cas protein; The second V-type Cas protein is a VB-type Cas protein.
7. A kit for detecting a target nucleic acid molecule, characterized in that: The kit comprises: Containers No. 1 to N and nucleic acid detection compositions No. 1 to N located in the containers No. 1 to N, wherein the nucleic acid detection compositions No. 1 to N include corresponding Cas proteins No. 1 to N, corresponding guide RNAs No. 1 to N, corresponding Cas protein trans-cleavage reporter molecules No. 1 to N and corresponding oligonucleotides No. 1 to N or oligonucleotide analogs; the Cas protein is a V-type Cas protein; the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N is higher than the trans-cleavage activity temperature of the Cas protein in the nucleic acid detection composition No. N-1. or inactivation temperature, the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-1 is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N-2, and so on, the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of this number is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of the previous number, except when N=1; the guide RNA Nos. 1 to N include direct repeats (Direct Repeat, DR) sequence and a guide sequence capable of targeting the corresponding target sequences No. 1 to N; the Cas protein trans-cleavage reporter molecules No. 1 to N include the corresponding single-stranded nucleic acid molecules No. 1 to N or single-stranded nucleic acid analog molecules, and the single-stranded nucleic acid molecules No. 1 to N or single-stranded nucleic acid analog molecules do not hybridize with the guide sequence of the guide RNA in the system; and the oligonucleotides No. 1 to N or oligonucleotide analogs can be complementary to the corresponding Cas protein trans-cleavage reporter molecules No. 1 to N, and can form closed Cas protein trans-cleavage reporter molecules No. 1 to N, and the trans-cleavage activity temperature of the Cas proteins No. 1 to N matches the melting temperature of the corresponding closed Cas protein trans-cleavage reporter molecules No. 1 to N; wherein N is a positive integer ≥1, preferably, N is 1-20, more preferably, N is 1-15, and more preferably, N=1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11; and / or Containers No. 1' to N' and nucleic acid detection compositions No. 1' to N' located in the containers No. 1' to N', wherein the nucleic acid detection compositions No. 1' to N' include corresponding Cas proteins No. 1' to N', corresponding guide RNAs No. 1' to N', corresponding Cas protein trans-cleavage reporter molecules No. 1' to N' and corresponding oligonucleotides or oligonucleotide analogs No. 1' to N'; the Cas proteins are type VI Cas proteins; the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N' is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-1, the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-1 is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition No. N'-2, and so on. The trans-cleavage activity of the Cas protein in the nucleic acid detection composition of this number is The temperature or inactivation temperature is higher than the trans-cleavage activity temperature or inactivation temperature of the Cas protein in the nucleic acid detection composition of the previous number, except when N'=1'; the guide RNA No. 1' to N' includes a direct repeat (DR) sequence capable of binding to the corresponding Cas protein No. 1' to N' and a guide sequence capable of targeting the corresponding target sequence No. 1' to N'; the trans-cleavage reporter molecule of the Cas protein No. 1' to N' includes a corresponding single-stranded nucleic acid molecule No. 1' to N' or a single-stranded nucleic acid analog molecule, and the single-stranded nucleic acid molecule No. 1' to N' or a single-stranded nucleic acid analog molecule does not hybridize with the guide sequence of the guide RNA in the system; and the oligonucleotide No. 1' to N' or the oligonucleotide analog can be trans-cleaved with the corresponding Cas protein No. 1' to N' The reporter molecules are complementary to each other to form trans-cutting reporter molecules of Cas proteins blocked from 1' to N', and the trans-cutting activity temperature of Cas proteins from 1' to N' matches the melting temperature of the corresponding trans-cutting reporter molecules of Cas proteins blocked from 1' to N'; wherein N' is a positive integer ≥ 1', preferably, N' is 1'-20', more preferably, N' is 1'-15', and more preferably, N'=1', 2', 3', 4', 5', 6', 7', 8', 9', 10' or 11'.
8. A kit for multiplex detection of target nucleic acid molecules, characterized in that: The kit comprises: i) a first container and a first nucleic acid detection composition in the first container, wherein the first nucleic acid detection composition comprises a first V-type Cas protein and a first guide RNA, wherein the first guide RNA comprises a direct repeat (DR) sequence capable of binding to the first V-type Cas protein and a guide sequence capable of targeting a first target sequence, and the first V-type Cas protein is a V-type Cas protein other than a VB-type Cas protein; ii) a second container and a second nucleic acid detection composition in the second container, wherein the second nucleic acid detection composition comprises a second V-type Cas protein and a second guide RNA, wherein the second guide RNA comprises a direct repeat (DR) sequence capable of binding to the second V-type Cas protein and a guide sequence capable of targeting a second target sequence; the trans-cleavage activity temperature or inactivation temperature of the second V-type Cas protein is higher than the trans-cleavage activity temperature or inactivation temperature of the first V-type Cas protein, and the second V-type Cas protein is a VB-type Cas protein; iii) an optional third container and a third nucleic acid detection composition in the third container, wherein the third nucleic acid detection composition comprises a third type VI Cas protein and a third guide RNA, wherein the third guide RNA comprises a direct repeat (DR) sequence capable of binding to the third type VI Cas protein and a guide sequence capable of targeting a third target sequence, and the third type VI Cas protein is a type VI Cas protein other than a thermostable type VI Cas protein; iv) an optional fourth container and a fourth nucleic acid detection composition in the fourth container, wherein the fourth nucleic acid detection composition comprises a fourth type VI Cas protein and a fourth guide RNA, wherein the fourth guide RNA comprises a direct repeat (DR) sequence capable of binding to the fourth type VI Cas protein and a guide sequence capable of targeting a fourth target sequence, the trans-cleavage activity temperature or inactivation temperature of the fourth type VI Cas protein is higher than the trans-cleavage activity temperature or inactivation temperature of the third type VI Cas protein, and the fourth type VI Cas protein is a heat-resistant type VI Cas protein; v) a fifth container and a first, second, optional third and optional fourth Cas protein trans-cleavage reporter molecule located in the fifth container, wherein the first, second, optional third and optional fourth Cas protein trans-cleavage reporter molecule each independently has a single-stranded nucleic acid molecule or a single-stranded nucleic acid analog molecule that does not hybridize with the guide sequence of the guide RNA in the kit; vi) a sixth container and an oligonucleotide (oligo) or oligonucleotide analog complementary to the second Cas protein trans-cleavage reporter molecule located in the sixth container and an optional oligonucleotide or oligonucleotide analog complementary to the fourth Cas protein trans-cleavage reporter molecule; Oligonucleotide (oligo) or oligonucleotide analog; the second Cas protein trans-cutting reporter molecule and the optional fourth Cas protein trans-cutting reporter molecule independently form a second closed Cas protein trans-cutting reporter molecule and an optional fourth closed Cas protein trans-cutting reporter molecule with their corresponding oligonucleotides or oligonucleotide analogs, and the melting temperature of the second closed Cas protein trans-cutting reporter molecule matches the trans-cutting activity temperature of the second V-type Cas protein; the melting temperature of the fourth Cas protein trans-cutting reporter molecule matches the trans-cutting activity temperature of the fourth VI-type Cas protein.
9. A method for detecting a target nucleic acid molecule, characterized in that: The method comprises subjecting the sample to be detected to the following reaction: i) contacting the sample to be detected with the detection system for detecting target nucleic acid molecules according to claim 5, and reacting at a first detection temperature; ii) detecting the detectable signal generated by the trans-cleavage reporter molecule No. 1 and / or the trans-cleavage reporter molecule No. 1' of the Cas protein in the detection system, thereby detecting the target sequence No. 1 corresponding to the trans-cleavage reporter molecule No. 1 and / or the target sequence No. 1' corresponding to the trans-cleavage reporter molecule No. 1' of the Cas protein; iii) gradually increasing the temperature, gradually allowing the next closed Cas protein trans-cleavage reporter molecule to release the corresponding Cas protein trans-cleavage reporter molecule and inactivating the current Cas protein, and detecting the detectable signal generated by the next Cas protein trans-cleavage reporter molecule (for example, allowing the closed Cas protein trans-cleavage reporter molecule in the Nth nucleic acid detection composition to release the corresponding Cas protein trans-cleavage reporter molecule and inactivating the N-1 Cas protein, allowing the closed Cas protein trans-cleavage reporter molecule in the N-1 nucleic acid detection composition to release the corresponding Cas protein trans-cleavage reporter molecule and inactivating the N-2 Cas protein, and so on, except when N=1), thereby detecting the corresponding target sequence.
10. A method for multiplex detection of target nucleic acid molecules, characterized in that: The method comprises subjecting the sample to be detected to the following reaction: i) contacting the sample to be detected with the multiple detection system for detecting target nucleic acid molecules as claimed in claim 6, and reacting at a first temperature; ii) detecting a detectable signal generated by the first Cas protein trans-cleaving the reporter molecule, and optionally the third Cas protein trans-cleaving the reporter molecule in the detection system, thereby detecting the first and / or third target sequence; iii) carrying out the reaction at a second temperature; iv) detecting a detectable signal generated by the second Cas protein trans-cleaving the reporter molecule, optionally the fourth Cas protein trans-cleaving the reporter molecule, thereby detecting the second target sequence and / or the fourth target sequence, wherein the first temperature is lower than the second temperature.
Citation Information
Patent Citations
Nucleic acid detection method based on CRISPR-Cas autocatalytic amplification network and application of nucleic acid detection method
CN112251494A
Fluorescent sensor for detecting miRNA by combining CTSDR and CRISPR / Cas, and preparation and application of fluorescent sensor
CN112626179A
Kit and method for detecting RNA (Ribonucleic Acid) at normal temperature
CN115820809A
Nucleic acid molecule for CRISPR cascade nucleic acid detection system and application
CN115976164A
Crispr cascade assay
US20230042422A1
Cited By
CRISPR-Cas12b (clustered regularly interspaced short palindromic repeats-CRISPR-Cas12b) temperature control one-step method pathogen nucleic acid
CN119464574A
D-p driving probe and Cas12a cascade amplification method based on same
CN120966820A
System and method for detecting exon jump mutation and application
CN121450804A
